#  @SenefLiveEvents Senef AS Senef AS posts on X about $mcrb, $nsrgy, $nvs, $mrk the most. They currently have [-----] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours. ### Engagements: [--] [#](/creator/twitter::209996110/interactions)  - [--] Week [-----] +367% - [--] Month [-----] -61% - [--] Months [------] +69% - [--] Year [------] +13% ### Mentions: [--] [#](/creator/twitter::209996110/posts_active)  - [--] Month [--] -28% - [--] Months [--] +100% - [--] Year [---] +133% ### Followers: [-----] [#](/creator/twitter::209996110/followers)  - [--] Week [-----] -0.14% - [--] Month [-----] -0.07% - [--] Months [-----] -0.56% - [--] Year [-----] -0.49% ### CreatorRank: [---------] [#](/creator/twitter::209996110/influencer_rank)  ### Social Influence **Social category influence** [stocks](/list/stocks) [finance](/list/finance) [cryptocurrencies](/list/cryptocurrencies) [technology brands](/list/technology-brands) [currencies](/list/currencies) [countries](/list/countries) [social networks](/list/social-networks) [financial services](/list/financial-services) [travel destinations](/list/travel-destinations) [automotive brands](/list/automotive-brands) **Social topic influence** [$mcrb](/topic/$mcrb), [$nsrgy](/topic/$nsrgy), [$nvs](/topic/$nvs), [$mrk](/topic/$mrk), [$jnj](/topic/$jnj) #44, [$xbi](/topic/$xbi) #53, [$pfe](/topic/$pfe), [$auph](/topic/$auph), [$ibb](/topic/$ibb) #15, [$sny](/topic/$sny) **Top accounts mentioned or mentioned by** [@monacobiotech](/creator/undefined) [@unemon1](/creator/undefined) [@maximusholla](/creator/undefined) [@auriniapharma](/creator/undefined) [@bharringtonw11](/creator/undefined) [@tomsilver39](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@zakstraderscafe](/creator/undefined) [@kaniel2909](/creator/undefined) [@mroliverbarnes](/creator/undefined) [@jfkamerica](/creator/undefined) [@semodough](/creator/undefined) [@astrazeneca](/creator/undefined) [@seedy19tron](/creator/undefined) [@rnaianalyst](/creator/undefined) [@doepkemichel](/creator/undefined) [@apexonco](/creator/undefined) [@mwm76](/creator/undefined) [@idorsia](/creator/undefined) [@deutschebank](/creator/undefined) **Top assets mentioned** [Novartis AG (NVS)](/topic/$nvs) [Merck & Co., Inc. (MRK)](/topic/$mrk) [Johnson & Johnson (JNJ)](/topic/$jnj) [Pfizer, Inc. (PFE)](/topic/$pfe) [Synthetify (SNY)](/topic/$sny) [Bristol-Myers Squibb Co (BMY)](/topic/$bmy) [Eli Lilly and Company (LLY)](/topic/$lly) [AstraZeneca PLC (AZN)](/topic/$azn) [GSK plc (GSK)](/topic/$gsk) [Impossible Finance Launchpad (IDIA)](/topic/$idia) [ROGin AI (ROG)](/topic/$rog) [AbbVie Inc (ABBV)](/topic/$abbv) [Incyte Corporation (INCY)](/topic/$incy) [Sanofi (SNY)](/topic/sanofi) [Abivax SA (ABVX)](/topic/$abvx) [Cytokinetics Inc. (CYTK)](/topic/$cytk) [NVIDIA Corp. (NVDA)](/topic/$nvda) [Novo-Nordisk (NVO)](/topic/$nvo) [TG Therapeutics, Inc. (TGTX)](/topic/$tgtx) [Viking Therapeutics, Inc (VKTX)](/topic/$vktx) [Microsoft Corp. (MSFT)](/topic/$msft) [SpringWorks Therapeutics, Inc. Common Stock (SWTX)](/topic/$swtx) [Vertex Protocol (VRTX)](/topic/$vrtx) [Gilead Sciences, Inc. (GILD)](/topic/$gild) [Intel Corporation (INTC)](/topic/$intc) [Advanced Micro Devices (AMD)](/topic/$amd) [Oracle Corporation (ORCL)](/topic/$orcl) [UnitedHealth Group (UNH)](/topic/$unh) [Cidara Therapeutics, Inc. (CDTX)](/topic/$cdtx) [Amgen, Inc. (AMGN)](/topic/$amgn) [Viking Holdings Ltd (VIK)](/topic/$vik) [Avidity Biosciences, Inc. (RNA)](/topic/$rna) [UBS Group AG (UBS)](/topic/$ubs) [Biogen Inc (BIIB)](/topic/$biib) [Mirati Therapeutics, Inc. Common Stock (MRTX)](/topic/$mrtx) [MGM Resorts International (MGM)](/topic/$mgm) [DraftKings Inc. Class A Common Stock (DKNG)](/topic/$dkng) [SPDR S&P [---] ETF Trust (SPY)](/topic/$spy) [Amazon.com, Inc. (AMZN)](/topic/$amzn) [Super Micro Computer, Inc. Common Stock (SMCI)](/topic/$smci) ### Top Social Posts Top posts by engagements in the last [--] hours "Look like a good opportunity to build a position in Vodafone $VOD today 🤔 $MSFT $SCMN #telecom Vodaphone take over speculation Goldman Sachs a potential buyer $VOD https://t.co/fmSYSgKtYh Vodaphone take over speculation Goldman Sachs a potential buyer $VOD https://t.co/fmSYSgKtYh" [X Link](https://x.com/SenefLiveEvents/status/1767925288707514738) 2024-03-13T14:46Z [----] followers, [----] engagements "After the deal with Swisscom Whats the next move for Vodafone @bharringtonw11 mentioned a full takeover with a rare alert 🤔 Still a good deal $VOD $MSFT $SCMN $ORA #iliad #telecommunications Look like a good opportunity to build a position in Vodafone $VOD today 🤔 $MSFT $SCMN #telecom Look like a good opportunity to build a position in Vodafone $VOD today 🤔 $MSFT $SCMN #telecom" [X Link](https://x.com/SenefLiveEvents/status/1770163279286927524) 2024-03-19T18:59Z [----] followers, [----] engagements "Look good for a company with a market cap of 113M : Seres is actively seeking a partner to provide financial resources and other capabilities to support the Companys goal SER-155 clinical trial showed 77% reduction in bloodstream infections Received $175M from VOWS $MCRB $NSRG Seres Therapeutics Reports Third Quarter [----] Financial Results and Provides Business Updates $MCRB https://t.co/KKaRdysYED Seres Therapeutics Reports Third Quarter [----] Financial Results and Provides Business Updates $MCRB https://t.co/KKaRdysYED" [X Link](https://x.com/SenefLiveEvents/status/1856671537048289308) 2024-11-13T12:12Z [----] followers, [----] engagements "Look good for build a position today in Incyte a lot of rumors the past days $INCY $NVS $SNY $INCY (-11.0% pre) Incyte drops after pausing enrollment in study for urticaria asset - SA https://t.co/QWO1lfwEeT $INCY (-11.0% pre) Incyte drops after pausing enrollment in study for urticaria asset - SA https://t.co/QWO1lfwEeT" [X Link](https://x.com/SenefLiveEvents/status/1858884220069834935) 2024-11-19T14:45Z [----] followers, [---] engagements "Mkt value 147M today for Seres $MCRB its still undervalued Fact are Nestle have invested a ton of money in this company Do you really still believe that they will not go further Do your own diligence and thank me later 🙃 $NSRGY $MRK $PFE $JNJ We are at 100M mkt So far Nestle has invested around 850M since [----] with the first partnership and the Vowst without the milestones Do you really believe that they will not go further $MCRB $NSRGY $MRK $PFE $JNJ We are at 100M mkt So far Nestle has invested around 850M since [----] with the first partnership and the Vowst without the milestones Do you" [X Link](https://x.com/SenefLiveEvents/status/1861100081727815894) 2024-11-25T17:30Z [----] followers, [----] engagements "What is cooking with Seres and Nestle Latest update and news on website of Nestle Health its the [--] August [--] Since none update about the Vowst deal and the future $MCRB $NSRG $XBI $IBB Lets go Seres its time to shine 77% relative risk reduction in bacterial bloodstream infections versus placebo Whats the next step Fast track partnership 🤔 $MCRB $NSRGY $NVS $MRK $JNJ Lets go Seres its time to shine 77% relative risk reduction in bacterial bloodstream infections versus placebo Whats the next step Fast track partnership 🤔 $MCRB $NSRGY $NVS $MRK $JNJ" [X Link](https://x.com/SenefLiveEvents/status/1875164086104904164) 2025-01-03T12:55Z [----] followers, [---] engagements "$MCRB Seres nominate Hans-Juergen Woerle Chief Scientific and Medical Officer Hans-Juergen is responsible for the companys global research and development strategy including translational science clinical development regulatory affairs market access and medical affairs. Very interesting presentation for Seres - https://t.co/EMSmKlL2Lt good opportunity again today😉 $MCRB $NSRGY $JNJ $LLY #Nestle #biotech https://t.co/ZWHFxtsvx1 Very interesting presentation for Seres - https://t.co/EMSmKlL2Lt good opportunity again today😉 $MCRB $NSRGY $JNJ $LLY #Nestle #biotech https://t.co/ZWHFxtsvx1" [X Link](https://x.com/SenefLiveEvents/status/1889339219828511001) 2025-02-11T15:42Z [----] followers, [---] engagements "The portfolios on which he and his team work span pediatric allergies to oncology to obesity and diabetes to inborn errors of metabolism and more. Thats mean something is cooking behind the scene Partnership or Buyout Make your beats and doo your DD $NSRGY $MRK $SNY" [X Link](https://x.com/SenefLiveEvents/status/1889339224056361314) 2025-02-11T15:42Z [----] followers, [---] engagements "If we can see similar scenario with Orsted $orsted #energy https://www.doi.dk/en/artikel/norske-opkoebsrygter-sender-oersted-aktien-i-moerkegroent https://www.doi.dk/en/artikel/norske-opkoebsrygter-sender-oersted-aktien-i-moerkegroent" [X Link](https://x.com/SenefLiveEvents/status/1902277982984560739) 2025-03-19T08:36Z [----] followers, [---] engagements "When the deal will be closed for Gerresheimer CEO On Call Says Takeover Talks Are Ongoing on April [--] [----] $GXI $GXI.DE #warburgpincus #ADIA" [X Link](https://x.com/SenefLiveEvents/status/1914773091416240310) 2025-04-22T20:07Z [----] followers, [---] engagements "SpringWorks deal with Merck its a good deal $SWTX $MRK.DE Yes No 57$ minimum Yes No 57$ minimum" [X Link](https://x.com/SenefLiveEvents/status/1916822037290496368) 2025-04-28T11:49Z [----] followers, [---] engagements "$SNY Sanofi buy the blueprint Medicines $BPMC its the second deal for Sanofi this year #biotech $ibb $xbi $SNY $BPMC Press Release: Sanofi to acquire Blueprint Medicines expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology $129.00 per share in cash at closing $9.1 billion + CVR https://t.co/OFYq1uhj53 $SNY $BPMC Press Release: Sanofi to acquire Blueprint Medicines expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology $129.00 per share in cash at closing $9.1 billion + CVR https://t.co/OFYq1uhj53" [X Link](https://x.com/SenefLiveEvents/status/1929416140171644953) 2025-06-02T05:53Z [----] followers, [---] engagements "Over the last three months the stock of Seres has risen 150%. How much do you think it can do over the next [--] months The FDA return could now come at any time.What are the advanced discussions with the different parties In [--] months it's Christmas🎅🏻 $MCRB $NSRGY $XBI $IBB Mmmm Seres Therapeutics whats is this options calls of October mean 15$ buyer for a value of 800K last week and yesterday buyer of 17.5$ for a value of 600K $MCRB $NSRGY $UNH #biotech #microbiome #optionsalerts Mmmm Seres Therapeutics whats is this options calls of October mean 15$ buyer for a value of 800K last week and" [X Link](https://x.com/SenefLiveEvents/status/1960992610585080131) 2025-08-28T09:07Z [----] followers, [----] engagements "📊 What the chart shows: Strong rally from $6.20 in early April to $17.40 by early September (+181%). 📊 Key insights from the chart: $MCRB : April 2025: $6.20 Early Sept 2025: $17.40 (+181%) Spiked above $22 intraday after the Sept [--] Nestl $41/share bid" [X Link](https://x.com/SenefLiveEvents/status/1966717653298372758) 2025-09-13T04:16Z [----] followers, [----] engagements "Good Morning World 🌍 another one ☝🏼 $RHHBY Roche enters into a definitive merger agreement to acquire 89bio $ETNB and its phase [--] FGF21 analog for the therapy of moderate to severe MASH. $14.50 + $6 CVR #biotech $xbi $mcrb $zvra next one https://finance.yahoo.com/news/89bio-inc-announces-agreement-acquired-050200298.html https://finance.yahoo.com/news/89bio-inc-announces-agreement-acquired-050200298.html" [X Link](https://x.com/SenefLiveEvents/status/1968556473291575328) 2025-09-18T06:03Z [----] followers, [---] engagements "Canaccord raised the price target on Seres Therapeutics to $22 from $14 and keeps a Buy rating on the shares. The firm noted the FDA provided feedback on Seres proposed Phase [--] SER-155 study in bloodstream infections which could aid in partnership discussions $MCRB $XBI $NSRGY Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase [--] Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway $MCRB https://t.co/ejAsK9VSQf Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase [--] Study Protocol and Implements Cost" [X Link](https://x.com/SenefLiveEvents/status/1970810248878563609) 2025-09-24T11:19Z [----] followers, [---] engagements "Monday buyout $GMAB GENMAB TO ACQUIRE $MRUS MERUS FOR $97 PER SHARE IN AN ALL-CASH TRANSACTION VALUED AT $8 BILLION #biotech $XBI $IBB" [X Link](https://x.com/SenefLiveEvents/status/1972574156131836310) 2025-09-29T08:08Z [----] followers, [---] engagements "I find this news from NHS very interesting. they havent announced anything since the VOWST. and just three days after the news from Seres they are looking for candidates in the same sector 🤔 Whats thats mean Maybe something maybe nothing $MCRB https://www.nestlehealthscience.com/newsroom/press-releases/applications-for-grants https://www.nestlehealthscience.com/newsroom/press-releases/applications-for-grants" [X Link](https://x.com/SenefLiveEvents/status/1973807512856969274) 2025-10-02T17:49Z [----] followers, [---] engagements "Very good:H.C. Wainwright Assumed Coverage on $TGTX at Buy-$60 and said: An MS franchise in the making; we expect Briumvi's market penetration to grow significantly in the next few yearsestimate that SC Briumvi could take peak US revenues from $3.1B to $5.1B in [----]. $RHHBY $NVS" [X Link](https://x.com/SenefLiveEvents/status/1975604508316344835) 2025-10-07T16:49Z [----] followers, [---] engagements "$MCRB Seres cut staff following Nestls request Nestle will cut [-----] jobs and the stock is soaring on the Swiss market by more than 8%. The forecasts are interesting for the NHS because the entity is being maintained and is moving more towards the medical & microbiome $NSRGY" [X Link](https://x.com/SenefLiveEvents/status/1978772075964694939) 2025-10-16T10:36Z [----] followers, [---] engagements "Dj vu $AVDL $MCRB $AVDL - many will say not much premium today on the buyout - but $AVDL one of those Biotechs that turned profitable and is up nicely from lows $AVDL - many will say not much premium today on the buyout - but $AVDL one of those Biotechs that turned profitable and is up nicely from lows" [X Link](https://x.com/SenefLiveEvents/status/1980957354578391060) 2025-10-22T11:20Z [----] followers, [---] engagements "Nothing as changed for Seres Therapeutics. Short are covering but stock its not moving in the right way Very strange We are at 22$ on the [--] October Announcement possible at any days now Seat your belt 🚀 $NSRGY $NVS #biotech #merger" [X Link](https://x.com/SenefLiveEvents/status/1983203267199860830) 2025-10-28T16:04Z [----] followers, [--] engagements "@Kaniel2909 Yes 🙏🏼 a good news today for $MCRB I hope more are coming in the next days - https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-receives-award-36-million-carb-x-develop https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-receives-award-36-million-carb-x-develop" [X Link](https://x.com/SenefLiveEvents/status/1983537823337627816) 2025-10-29T14:14Z [----] followers, [--] engagements "Wow what a crazy story I have sold all my position this year $AUPH $AUPH Turns out that the LinkedIn post may not have been the height of it if even half of what is alleged in lawsuit is true: https://t.co/CazfhuYZnn $AUPH Turns out that the LinkedIn post may not have been the height of it if even half of what is alleged in lawsuit is true: https://t.co/CazfhuYZnn" [X Link](https://x.com/SenefLiveEvents/status/1985275118902301158) 2025-11-03T09:17Z [----] followers, [---] engagements "Seres Therapeutics advanced earnings on the [--] November Jurisdiction vs Vedanta are on the [--] November with Nestle hand in hand represented by the same lawyers Whats the next move Buyout or partnership on the [--] November $MCRB $NSRGY $VEDL $XBI #biotech" [X Link](https://x.com/SenefLiveEvents/status/1985677989741543486) 2025-11-04T11:58Z [----] followers, [---] engagements "Interesting 🧐 A deal between SoftBank & Marvell this two make senses $MRVL $9984.TO SoftBank explored a potential takeover of US chipmaker Marvell Technology earlier this year sources say in what would have been the semiconductor industrys largest-ever deal https://t.co/ecPKpWIjV9 SoftBank explored a potential takeover of US chipmaker Marvell Technology earlier this year sources say in what would have been the semiconductor industrys largest-ever deal https://t.co/ecPKpWIjV9" [X Link](https://x.com/SenefLiveEvents/status/1986410829843972106) 2025-11-06T12:30Z [----] followers, [---] engagements "Merck $MRK is nearing a deal to buy Cidara Therapeutics $CDTX $XBI $IBB whos next Seres Therapeutics 🙃 $MCRB Merck $MRK is nearing a deal to buy Cidara Therapeutics $CDTX a drugmaker pioneering a long-acting antibody medicine that protects against flu FT reported. @mroliverbarnes @JFK_America A deal valuing Cidara at a premium to its $3.3 billion market capitalisation could be https://t.co/AeXmvK0MYf Merck $MRK is nearing a deal to buy Cidara Therapeutics $CDTX a drugmaker pioneering a long-acting antibody medicine that protects against flu FT reported. @mroliverbarnes @JFK_America A deal" [X Link](https://x.com/SenefLiveEvents/status/1989259977220132982) 2025-11-14T09:11Z [----] followers, [---] engagements "I like this one $CRSP Crispr Therapeutics will attract a lot of potential buyers Possible target $100 $AMGN $JNJ $ROG.SW #biotech #gene $CRSP +5% CRISPR Therapeutics shares climbed after rumors suggested a large U.S. biopharma company may be exploring a potential acquisition fueled by progress in gene editing programs and growing Casgevy sales. https://t.co/uBxRuFwy04 https://t.co/meZEEDSeRk $CRSP +5% CRISPR Therapeutics shares climbed after rumors suggested a large U.S. biopharma company may be exploring a potential acquisition fueled by progress in gene editing programs and growing Casgevy" [X Link](https://x.com/SenefLiveEvents/status/1990549025339412841) 2025-11-17T22:34Z [----] followers, [---] engagements "$MCRB The current fair price should be $25-30. Did you remember that : Pursuant to the Purchase Agreement Seres and Nestl Health Science will share 50/50 in the net profit or net loss achieved during the Profit Sharing Period from the date of Closing until December [--] 2025" [X Link](https://x.com/SenefLiveEvents/status/1990550498399986113) 2025-11-17T22:39Z [----] followers, [---] engagements "LOL just in time with the news results of Viking Therapeutics :) Hey Pfizer whats the offer $PFE $VKTX #biotech #obesity $PFE Pfizer CFO: Company To Look Globally For More Obesity Deals - Will Look To Supplement Metsera Assets $PFE Pfizer CFO: Company To Look Globally For More Obesity Deals - Will Look To Supplement Metsera Assets" [X Link](https://x.com/SenefLiveEvents/status/1991073372235518201) 2025-11-19T09:17Z [----] followers, [---] engagements "$LLY #1 *ELI LILLY BECOMES FIRST HEALTH-CARE COMPANY WORTH $1 TRILLION $LLY https://t.co/Nb9wonlXeF *ELI LILLY BECOMES FIRST HEALTH-CARE COMPANY WORTH $1 TRILLION $LLY https://t.co/Nb9wonlXeF" [X Link](https://x.com/SenefLiveEvents/status/1991885949106819286) 2025-11-21T15:06Z [----] followers, [---] engagements "The Art of the negotiations between Novartis & Avidity Bio. $NVS $RNA #biotech M&A $NVS / $RNA Prem14A July 3: $52/share July 9: $60/share July 21: $70/share September 19: $72/share October 26: Deal disclosed Also $RNA disclosed plans to conduct a $500m offering on September [--] https://t.co/xii3qznpby $NVS / $RNA Prem14A July 3: $52/share July 9: $60/share July 21: $70/share September 19: $72/share October 26: Deal disclosed Also $RNA disclosed plans to conduct a $500m offering on September [--] https://t.co/xii3qznpby" [X Link](https://x.com/SenefLiveEvents/status/1993141109703557351) 2025-11-25T02:14Z [----] followers, [---] engagements "@semodough Its still a buyout candidate 🙃" [X Link](https://x.com/SenefLiveEvents/status/1995816017121902883) 2025-12-02T11:23Z [----] followers, [--] engagements "Look like a big premium its coming for $ABVX this story remember me $CDTX 😉#biotech $SNY $AZN $ABVX Now they have added Dec19 [---] calls for 400k with one week to expiration https://t.co/81eUOCAPJ9 $ABVX Now they have added Dec19 [---] calls for 400k with one week to expiration https://t.co/81eUOCAPJ9" [X Link](https://x.com/SenefLiveEvents/status/1998417839318093830) 2025-12-09T15:41Z [----] followers, [---] engagements "Be careful sometimes we win but the losses are always bigger $RZLT $ABVX #Biotech Botech in nutshell $ABVX (LP+C) from [--] to [---] with good data $RZLT (NP) FROM [--] to [---] at bad data Botech in nutshell $ABVX (LP+C) from [--] to [---] with good data $RZLT (NP) FROM [--] to [---] at bad data" [X Link](https://x.com/SenefLiveEvents/status/1999117726686523889) 2025-12-11T14:03Z [----] followers, [---] engagements "Very good news for the science & the breast cancer I hope this saves more life @AstraZeneca #biotech #breastcancerawareness $AZN $ROG.SW $AZN FDA approval FDA approves fam-trastuzumab deruxtecan-nxki with pertuzumab for unresectable or metastatic HER2-positive breast cancer FDA $AZN FDA approval FDA approves fam-trastuzumab deruxtecan-nxki with pertuzumab for unresectable or metastatic HER2-positive breast cancer FDA" [X Link](https://x.com/SenefLiveEvents/status/2000643703166099725) 2025-12-15T19:06Z [----] followers, [--] engagements "If down to 95-105$ I will add I dont see a quick buyout before the end of this year But I like the research of @seedy19tron 👌🏼 $ABVX $LLY $SNY $AZN Just correcting some misinformation on this app re $abvx 1) the marketing expense going down is misleading. 1.7m decrease but there was a 1.8m one time cost last year for the same period. So thats actually a 0.1m increase not including that one time cost of rebranding. Just correcting some misinformation on this app re $abvx 1) the marketing expense going down is misleading. 1.7m decrease but there was a 1.8m one time cost last year for the same" [X Link](https://x.com/SenefLiveEvents/status/2000866556058722636) 2025-12-16T09:52Z [----] followers, [----] engagements "Can we see a hostile takeover for Wave $WVE by GlaxoSmithKline $GSK soon 🤔 $GSK acquires [---] million shares of $WVE at open market $XBI $IBB https://t.co/eqcc8O8iHf $GSK acquires [---] million shares of $WVE at open market $XBI $IBB https://t.co/eqcc8O8iHf" [X Link](https://x.com/SenefLiveEvents/status/2000874886856855603) 2025-12-16T10:25Z [----] followers, [---] engagements "Boom Now its a candidate for a buyout $CYTK Cytokinetics Announces FDA Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms" [X Link](https://x.com/SenefLiveEvents/status/2002295330000273872) 2025-12-20T08:29Z [----] followers, [----] engagements "AST space mobile to the moon 🌖 $ASTS BlueBird [--] has left the factory and is headed to space Next stop: Cape Canaveral Florida🚀🚀🚀🚀🚀🚀🚀 Identical to BlueBird [--] BlueBird [--] will also be the largest commercial communications satellite ever launched into low Earth orbit. This marks another milestone as we https://t.co/VWtY8LbibL BlueBird [--] has left the factory and is headed to space Next stop: Cape Canaveral Florida🚀🚀🚀🚀🚀🚀🚀 Identical to BlueBird [--] BlueBird [--] will also be the largest commercial communications satellite ever launched into low Earth orbit. This marks another milestone as" [X Link](https://x.com/SenefLiveEvents/status/2002825329484997056) 2025-12-21T19:35Z [----] followers, [---] engagements "@RNAiAnalyst The past news concerning Rexel was demented by the company for information" [X Link](https://x.com/SenefLiveEvents/status/2003106853589504178) 2025-12-22T14:14Z [----] followers, [---] engagements "+9% $CYTK who will be the buyer 🤔 $PFE $MRK $NVS $LLY $ROG Boom Now its a candidate for a buyout $CYTK Cytokinetics Announces FDA Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms Boom Now its a candidate for a buyout $CYTK Cytokinetics Announces FDA Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms" [X Link](https://x.com/SenefLiveEvents/status/2003112297380843733) 2025-12-22T14:36Z [----] followers, [---] engagements "@doepke_michel Nothing for Pfizer & Sanofi $PFE & $SNY" [X Link](https://x.com/SenefLiveEvents/status/2005400730598019124) 2025-12-28T22:09Z [----] followers, [---] engagements "Deal done for $OS at 24$ share. I think the price is low. I would have expected 30$ 🤔 Buyout firm Hg Capital is in advanced talks to acquire OneStream $OS and could announce a deal in the coming days per Bloomberg. https://t.co/2lLqHwYvn3 Buyout firm Hg Capital is in advanced talks to acquire OneStream $OS and could announce a deal in the coming days per Bloomberg. https://t.co/2lLqHwYvn3" [X Link](https://x.com/SenefLiveEvents/status/2008589645505065201) 2026-01-06T17:21Z [----] followers, [---] engagements "Eli Lilly $LLY we go first with Ventyx $VTYX after closing this deal maybe will come back on the table for $ABVX 🤔 WSJ reports Eli Lilly $LLY is in advanced talks to buy Ventyx Biosciences $VTYX for more than $1B and a deal could be announced soon. Ventyx develops oral drugs for inflammatory diseases including NLRP3-targeting candidates and a mid-stage asset for cardiovascular disease https://t.co/z44NWUeah4 WSJ reports Eli Lilly $LLY is in advanced talks to buy Ventyx Biosciences $VTYX for more than $1B and a deal could be announced soon. Ventyx develops oral drugs for inflammatory diseases" [X Link](https://x.com/SenefLiveEvents/status/2008656007153742053) 2026-01-06T21:44Z [----] followers, [---] engagements "Lets go 🚀 $XBI $IBB $XBI THERE WILL BE LARGE LATE STAGE TO COMMERCIAL M&A DEALS LIKE ITCI IN [----] - CENTERVIEWS ERIC TOKAT $XBI THERE WILL BE LARGE LATE STAGE TO COMMERCIAL M&A DEALS LIKE ITCI IN [----] - CENTERVIEWS ERIC TOKAT" [X Link](https://x.com/SenefLiveEvents/status/2008998247428477286) 2026-01-07T20:24Z [----] followers, [---] engagements "Not sure that Sanofi $SNY Will buy $OCUL more better competitors in this segment #biotech $OCUL: Sanofi is preparing an improved takeover bid for Ocular Therapeutix after its initial $16-per-share offer was rejected by the board - per LaLettre https://t.co/gqiSUABntY $OCUL: Sanofi is preparing an improved takeover bid for Ocular Therapeutix after its initial $16-per-share offer was rejected by the board - per LaLettre https://t.co/gqiSUABntY" [X Link](https://x.com/SenefLiveEvents/status/2011763856616669606) 2026-01-15T11:34Z [----] followers, [---] engagements "I sell my position yesterday at $311 🥲 $PEN $BSX #Healthcare $PEN $BSX Boston Scientific announces agreement to acquire Penumbra Inc. BioPharmCatalyst https://t.co/RdYIn7WbM4 $PEN $BSX Boston Scientific announces agreement to acquire Penumbra Inc. BioPharmCatalyst https://t.co/RdYIn7WbM4" [X Link](https://x.com/SenefLiveEvents/status/2011775499522158847) 2026-01-15T12:20Z [----] followers, [---] engagements "I like this one long a lot of potential for Archer Aviation $ACHR $ACHR Repeat buying on the 6/16 14c (far OTM) Always tricky playing a breakout especially with demark exhaustion firing here but that signal is not as strong without a big unplug imo so im not to believe this could go First TP would be the volume imbalance above https://t.co/6c1RPhXQlJ $ACHR Repeat buying on the 6/16 14c (far OTM) Always tricky playing a breakout especially with demark exhaustion firing here but that signal is not as strong without a big unplug imo so im not to believe this could go First TP would be the volume" [X Link](https://x.com/SenefLiveEvents/status/2012177086174085399) 2026-01-16T14:56Z [----] followers, [---] engagements "@Maximus_Holla @monaco_biotech This is like a Betaville number two" [X Link](https://x.com/SenefLiveEvents/status/2013537486413205835) 2026-01-20T09:02Z [----] followers, [---] engagements "@Maximus_Holla @monaco_biotech Lets see 🙃" [X Link](https://x.com/SenefLiveEvents/status/2013542761568346179) 2026-01-20T09:22Z [----] followers, [--] engagements "@Maximus_Holla @monaco_biotech "The first step before engaging the govt on this foreign direct investment regulation there must be a step number one: a public transaction communicated between the acquirer and the acquiree. That has not happened." - $ABVX CEO $LLY" [X Link](https://x.com/SenefLiveEvents/status/2013614881199497662) 2026-01-20T14:09Z [----] followers, [---] engagements "$CAP.pa buy $WNS for 76.50$ 3.3B Capgemini to Buy WNS for $3.3 Billion https://t.co/kUJ5WLCG5G Capgemini to Buy WNS for $3.3 Billion https://t.co/kUJ5WLCG5G" [X Link](https://x.com/SenefLiveEvents/status/1942100655004594287) 2025-07-07T05:57Z [----] followers, [---] engagements "$MCRB 80% in the last five days and short not covering 🤔 We know the company are backed by Nestle for the Moment. The future of the Microbiome its brillant with a big market value estimates range: $1.3B (2024) growing to $8.9B by 2034; other estimates project $1.27B$2.26B" [X Link](https://x.com/SenefLiveEvents/status/1991386365305721311) 2025-11-20T06:01Z [----] followers, [---] engagements "I like actually $ASND & $GMAB two Nordic contenders with a big and promising pipeline 🚀 $PFE $NVS $NVO $ABBV Today upgrade for Genmab $GMAB $GMAB.CO of Deutsche Bank for a buy with a new target of [----] DK Still partnership with PfizerAbbvieBioNTech $PFE $ABBV $BNTX $NVS Today upgrade for Genmab $GMAB $GMAB.CO of Deutsche Bank for a buy with a new target of [----] DK Still partnership with PfizerAbbvieBioNTech $PFE $ABBV $BNTX $NVS" [X Link](https://x.com/SenefLiveEvents/status/2005764369981002167) 2025-12-29T22:14Z [----] followers, [---] engagements "Good entry point today for Ascendis - Upgraded by Wells for overweight 332$ - Disappointed by the news of Abivax $ASND $ABVX #biotech (3/n): $ASND Full-year [----] product revenue of 683m Expect operating cash flow of 500m in [----] Planned$120mshare repurchase program in [----] TransCon CNP PDUFA goal date ofFebruary [--] [----] https://t.co/V2jmjjfzlA (3/n): $ASND Full-year [----] product revenue of 683m Expect operating cash flow of 500m in [----] Planned$120mshare repurchase program in [----] TransCon CNP PDUFA goal date ofFebruary [--] [----] https://t.co/V2jmjjfzlA" [X Link](https://x.com/SenefLiveEvents/status/2010725625720664208) 2026-01-12T14:48Z [----] followers, [----] engagements "Poseida $PSTX with a mkt cap of 278M acquired by Roche $RHHBY for 1.5B before that stock go to 1.78$ thats company have also a partnership with Roche phase1 a lot of similarities with Seres $MCRB 😉 place your bets https://www.prnewswire.com/news-releases/poseida-therapeutics-inc-announces-agreement-to-be-acquired-by-roche-holdings-inc-302316189.html Roche enters into a definitive agreement to acquire Poseida Therapeutics. $1B plus a CVR. https://www.prnewswire.com/news-releases/poseida-therapeutics-inc-announces-agreement-to-be-acquired-by-roche-holdings-inc-302316189.html Roche enters into" [X Link](https://x.com/SenefLiveEvents/status/1861322097580007568) 2024-11-26T08:12Z [----] followers, [----] engagements "Novartis still strong $NVS $NOVN.SW Novartis reported a strong quarter with higher-than-expected net sales and core EPS though some drug sales like Cosentyx and Promacta/Revolade fell short of estimates. Novartis reported a strong quarter with higher-than-expected net sales and core EPS though some drug sales like Cosentyx and Promacta/Revolade fell short of estimates" [X Link](https://x.com/SenefLiveEvents/status/1945712599477154234) 2025-07-17T05:10Z [----] followers, [---] engagements "Make your own DD and you understand Since [----] Nestl Health Science has invested big in Seres Therapeutics: [----] $66.5M + $30M 💵 [----] $175M + $125M 📈 [----] $175M + $18M 🔄 [----] $50M + $25M 💰 Total so far: $664.5M Potential: +$275M milestones #biotech #Nestle $NSRGY $MCRB Over the last three months the stock of Seres has risen 150%. How much do you think it can do over the next [--] months The FDA return could now come at any time.What are the advanced discussions with the different parties In [--] months it's Christmas🎅🏻 $MCRB $NSRGY $XBI $IBB Over the last three months the stock of Seres has" [X Link](https://x.com/SenefLiveEvents/status/1963531408460181943) 2025-09-04T09:15Z [----] followers, [----] engagements "Nothing as changed for Seres Therapeutics. Short are covering but stock its not moving in the right way Very strange We are at 22$ on the [--] October Announcement possible at any days now Seat your belt 🚀 $MCRB $NSRGY $NVS #biotech #merger 📊 What the chart shows: Strong rally from $6.20 in early April to $17.40 by early September (+181%). 📊 Key insights from the chart: $MCRB : April 2025: $6.20 Early Sept 2025: $17.40 (+181%) Spiked above $22 intraday after the Sept [--] Nestl $41/share bid https://t.co/hmnE8oNuvl 📊 What the chart shows: Strong rally from $6.20 in early April to $17.40 by" [X Link](https://x.com/SenefLiveEvents/status/1983234202788143573) 2025-10-28T18:07Z [----] followers, [---] engagements "Permira and Warburg Pincus are nearing a deal to acquire investment software maker Clearwater Analytics $CWAN. A deal could be announced as soon as Monday barring any last-minute snags. 24.55$ not bad at all" [X Link](https://x.com/SenefLiveEvents/status/2002823501594718474) 2025-12-21T19:28Z [----] followers, [---] engagements "GSK $GSK & RAPT $RAPT Wedding 💍👰🏼 day for $58 Congrats 🎊 🙃 #biotech and of course Rapt participated at JPM #Healthcare GSK $GSK to Acquire RAPT Therapeutics $RAPT for $1.9 Billion - 🧬GSK will pay RAPT Therapeutics shareholders $58 per share representing a 65.24% premium from the stocks last close. 🧬A GSK subsidiary will begin a tender offer within [--] business days. 🧬The deal is expected to https://t.co/LwWsxbL9js GSK $GSK to Acquire RAPT Therapeutics $RAPT for $1.9 Billion - 🧬GSK will pay RAPT Therapeutics shareholders $58 per share representing a 65.24% premium from the stocks last" [X Link](https://x.com/SenefLiveEvents/status/2013537290342056320) 2026-01-20T09:01Z [----] followers, [---] engagements "After the announcement of the partnership with Anthropic UBS upgrade : UBS raises its price target on Genmab to DKK2750 from DKK2700 while maintaining a Buy rating and naming it as top pick for European biotech in [----]. $GMAB $GMAB.co $JNJ $UBS #biotech Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic . https://t.co/l617ChPwXx #AgenticAI Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic . https://t.co/l617ChPwXx #AgenticAI" [X Link](https://x.com/SenefLiveEvents/status/2009211914019328263) 2026-01-08T10:33Z [----] followers, [---] engagements "Thats the reason Im buying Genmab at discount today $GMAB #biotech $XBI $IBB William Blair reiterated a Buy rating on #Genmab $GMAB citing limited risk to the accelerated approval of Epkinly despite mixed trial results. Truist Financial has similarly maintained a Buy rating with a $48.00 price target Barclays Maintained Buy dkk [-----] William Blair reiterated a Buy rating on #Genmab $GMAB citing limited risk to the accelerated approval of Epkinly despite mixed trial results. Truist Financial has similarly maintained a Buy rating with a $48.00 price target Barclays Maintained Buy dkk 2.500" [X Link](https://x.com/SenefLiveEvents/status/2013170810521804983) 2026-01-19T08:44Z [----] followers, [---] engagements "$GMAB Handelsbanken believes the market reaction is excessive given that the cancer drug Epkinly developed by the Danish pharmaceutical company Genmab did not clearly improve survival in a Phase [--] trial. This was stated in a commentary published Monday. The company's U.S. registered certificate fell 4.7% on Friday. In today's opening session on the Copenhagen Stock Exchange the share price declined by more than 5% in generally weak markets following Donald Trump's latest statements on tariffs. Handelsbanken emphasizes that Genmab remains one of its preferred Nordic stocks and indicates that" [X Link](https://x.com/SenefLiveEvents/status/2013190420881101307) 2026-01-19T10:02Z [----] followers, [---] engagements "Genmab will be a big winner this year 💪🏼 Average analyst price is $38 with a high at $48 undervalued a the actual price $GMAB $MRK $JNJ $NVO $XBI $IBB #Biotech With a tipoff from a friend and some info that probably shouldn't have been posted in a trial registry the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK have been revealed. Quite amazing given the recent $GMAB news. Via @ApexOnco - https://t.co/WT8gNUvT83 With a tipoff from a friend and some info that probably shouldn't have been posted in a trial registry the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK" [X Link](https://x.com/SenefLiveEvents/status/2018308282931191949) 2026-02-02T12:59Z [----] followers, [---] engagements "@bharringtonw11 Betaville spread a new rumor about Seres $MCRB its writes the Nestl would have done an new offer this summer Today Nestle its still one of the big owner of the company Look like something is cooking $NSRGY $NESN.SW $MRK $SNY $NVO #biotech $MCRB +9% amid takeover speculation. However the rumour hasnt been tested through formal journalistic channels. https://t.co/E7pX0mRYY7 $MCRB +9% amid takeover speculation. However the rumour hasnt been tested through formal journalistic channels. https://t.co/E7pX0mRYY7" [X Link](https://x.com/SenefLiveEvents/status/1844438580325913055) 2024-10-10T18:03Z [----] followers, [----] engagements "Nestl Health Science Turnaround on track double-digit growth Active and medical delivered strong growth 👍🏼 Full takeover of Seres its the next target 🤔 🎯 $MCRB $NSRGY $NESN.sw $MRK $SNY $NVO #biotech" [X Link](https://x.com/SenefLiveEvents/status/1846917039346024862) 2024-10-17T14:11Z [----] followers, [----] engagements "Seres green on a blood bath 🤔 what will be your vote I come soon with a post about my vote Lets go Nestle make it happen $MCRB $NESN.SW $NSRGY $MRK $JNJ $LLY #biotech You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for Seres. the die is cast in my opinion $MCRB $NSRGY $MRK $JNJ $NVS #Biotech You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for" [X Link](https://x.com/SenefLiveEvents/status/1904982026656285172) 2025-03-26T19:41Z [----] followers, [---] engagements "Dont miss to vote Last call Management as failed No value for shareholders of Seres I hope Nestle will be on the side of shareholders $MCRB $NSRGY $NESN.SW #biotech #pharma #tariffs To all Seres shareholders I recommend that you vote no to all the proposals. The board and management have brought no added value apart from a terrible fall in the share price. $MCRB $NSRGY #biotech #Nestle https://t.co/sFNoAyHHcz To all Seres shareholders I recommend that you vote no to all the proposals. The board and management have brought no added value apart from a terrible fall in the share price. $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1909290566409453680) 2025-04-07T17:01Z [----] followers, [----] engagements "$ORSTED.CO 👎🏼 Orsted shares crashed more than 25% on Monday morning after the wind farm developer said it plans a [--] billion Danish kroner ($9.4 billion) rights issue following a material adverse development in the U.S. market. Read Chloe Taylors article for more: https://t.co/wVsWLdwy6v https://t.co/2JVJEV91R9 Orsted shares crashed more than 25% on Monday morning after the wind farm developer said it plans a [--] billion Danish kroner ($9.4 billion) rights issue following a material adverse development in the U.S. market. Read Chloe Taylors article for more: https://t.co/wVsWLdwy6v" [X Link](https://x.com/SenefLiveEvents/status/1954819862812864875) 2025-08-11T08:19Z [----] followers, [--] engagements "9M-25 highlights: In Nestl Health Science OG for the first nine months was solid with all segments contributing to positive RIG-led growth. In VMS premium brands grew strongly partially offset by the discontinuation of some private label business" [X Link](https://x.com/SenefLiveEvents/status/1978772636302762000) 2025-10-16T10:38Z [----] followers, [---] engagements "and a weaker performance across some mainstream brands. In Active Nutrition Orgain sustained its strong growth momentum supported by new product launches. In Medical Nutrition solid growth was driven by pediatric care products. #biopharma #biotech $nesn.sw" [X Link](https://x.com/SenefLiveEvents/status/1978772639431700836) 2025-10-16T10:38Z [----] followers, [--] engagements "Dont worry @MWM76 Today will be a good day for $ALGN :) best management team for the 3rd time https://finance.yahoo.com/news/align-technology-recognized-3rd-time-000200123.html $ALGN silly downgrade right when ALGN is breaking out very sus. Fuck these clowns that play ball that way. I hope a buyout comes and cleans their clock. https://t.co/zghB95SKEt https://finance.yahoo.com/news/align-technology-recognized-3rd-time-000200123.html $ALGN silly downgrade right when ALGN is breaking out very sus. Fuck these clowns that play ball that way. I hope a buyout comes and cleans their clock." [X Link](https://x.com/SenefLiveEvents/status/1993565575885603075) 2025-11-26T06:20Z [----] followers, [---] engagements "Genmab its a very good company and this results are very good Adding more $GMAB #biotech New standard of care in 2L FL you can drive a truck through those curves Notably the three SUD dosing strategy is new SoC for Epkinly significantly reducing any grade/Gr3 CRS. Congrats to Falce et al. $GMAB #ASH25 https://t.co/bodTu1E6Ib New standard of care in 2L FL you can drive a truck through those curves Notably the three SUD dosing strategy is new SoC for Epkinly significantly reducing any grade/Gr3 CRS. Congrats to Falce et al. $GMAB #ASH25 https://t.co/bodTu1E6Ib" [X Link](https://x.com/SenefLiveEvents/status/1997965603106410814) 2025-12-08T09:44Z [----] followers, [---] engagements "Still in Genmab Actually my favorite one Sciences always win 😉 $GMAB $PFE Buy now or regret later 🙃 $GMAB $PFE #Biotech Buy now or regret later 🙃 $GMAB $PFE #Biotech" [X Link](https://x.com/SenefLiveEvents/status/2000875360859345108) 2025-12-16T10:27Z [----] followers, [---] engagements "Today upgrade for Genmab $GMAB $GMAB.CO of Deutsche Bank for a buy with a new target of [----] DK Still partnership with PfizerAbbvieBioNTech $PFE $ABBV $BNTX $NVS Still in Genmab Actually my favorite one Sciences always win 😉 $GMAB $PFE Still in Genmab Actually my favorite one Sciences always win 😉 $GMAB $PFE" [X Link](https://x.com/SenefLiveEvents/status/2001916233084735903) 2025-12-19T07:23Z [----] followers, [---] engagements "Telecom Italia $TIT.MI Win 1Billion plus 500M in interest Lets see hows the stock react tomorrow 🤔 Telecom Italia to hold Sunday board meeting on savings share conversion plan https://t.co/zlN0BBd6pz https://t.co/zlN0BBd6pz Telecom Italia to hold Sunday board meeting on savings share conversion plan https://t.co/zlN0BBd6pz https://t.co/zlN0BBd6pz" [X Link](https://x.com/SenefLiveEvents/status/2002824211287740735) 2025-12-21T19:31Z [----] followers, [---] engagements "Nice premium 320% for Vigil Neuroscience $VIGL Sanofi $SNY paid 8$ +$2 CVR when its your turn Seres Therapeutics $MCRB Vigil Gets Scooped Up by Sanofi $SNY $VIGL Another neuro deal another reminder: in biotech clarity and timing still matter. Sanofi is acquiring Vigil Neuroscience for $8/share valuing the company at $470M upfront plus a $2/share CVR if the lead drug hits the market. Thats https://t.co/kUKP9EjGra Vigil Gets Scooped Up by Sanofi $SNY $VIGL Another neuro deal another reminder: in biotech clarity and timing still matter. Sanofi is acquiring Vigil Neuroscience for $8/share valuing" [X Link](https://x.com/SenefLiveEvents/status/1925479206848176170) 2025-05-22T09:09Z [----] followers, [---] engagements "Loading up on $GMAB before earnings. If they deliver a beat + fresh catalysts this thing wont stay at these levels for long. Added more yesterday. Lets see whos early. $JNJ $ABBV $NVO $PFE $GMAB $ABBV Genmab AbbVie #Epkinly $GMAB $ABBV Genmab AbbVie #Epkinly" [X Link](https://x.com/SenefLiveEvents/status/2021818841270198595) 2026-02-12T05:29Z [----] followers, [----] engagements "Now @Idorsia target is 30CHF by @DeutscheBank with very good analysis. Potential revenue of 4Billions with her actually Pipeline #idorsia #biotech #medical #drugs #pharma $IDIA" [X Link](https://x.com/SenefLiveEvents/status/1002122882980433920) 2018-05-31T09:41Z [----] followers, [--] engagements "Nice 👍🏼 $IDIA Thank you @Lundquist for the shout out Happy to see the results but the work is not done as we definitely have more improvements planned for [----]. Check out our website at https://t.co/ZsWVf08NDZ Thank you @Lundquist for the shout out Happy to see the results but the work is not done as we definitely have more improvements planned for [----]. Check out our website at https://t.co/ZsWVf08NDZ" [X Link](https://x.com/SenefLiveEvents/status/1082599779031572480) 2019-01-08T11:27Z [----] followers, [--] engagements "$IDIA Idorsia says stay tuned 🚀🚀🚀 UPDATE 2-Swiss Idorsia says 'stay tuned' for deals as it manages pipeline - Reuters UPDATE 2-Swiss Idorsia says 'stay tuned' for deals as it manages pipeline - Reuters" [X Link](https://x.com/SenefLiveEvents/status/1093788676889460736) 2019-02-08T08:28Z [----] followers, [--] engagements ""With Idorsia we do not want to repeat the Actelion story we want to much better" says J-P Clozel $IDIA Serial entrepreneurs par excellence - Martine and Jean-Paul Clozel on stage at #SEF19 : "With Idorsia we do not want to repeat the Actelion story we want to much better" https://t.co/Dl2M8WGPSq Serial entrepreneurs par excellence - Martine and Jean-Paul Clozel on stage at #SEF19 : "With Idorsia we do not want to repeat the Actelion story we want to much better" https://t.co/Dl2M8WGPSq" [X Link](https://x.com/SenefLiveEvents/status/1131851759641649152) 2019-05-24T09:17Z [----] followers, [--] engagements "$IDIA Clinical data for our investigational therapy for the treatment of adult and elderly patients with insomnia have been presented at #SLEEP2019 in San Antonio (Texas USA). Read more in our press release https://t.co/nUhPtm1Oak Clinical data for our investigational therapy for the treatment of adult and elderly patients with insomnia have been presented at #SLEEP2019 in San Antonio (Texas USA). Read more in our press release https://t.co/nUhPtm1Oak" [X Link](https://x.com/SenefLiveEvents/status/1139041812763463681) 2019-06-13T05:28Z [----] followers, [--] engagements "🧪 👨🍳 $IDIA Idorsia will be profitable in [----] Idorsia vise la rentabilit l'horizon [----] (CEO) https://t.co/W6cOa8kM92 #Idorsia Idorsia vise la rentabilit l'horizon [----] (CEO) https://t.co/W6cOa8kM92 #Idorsia" [X Link](https://x.com/SenefLiveEvents/status/1165921036682088450) 2019-08-26T09:36Z [----] followers, [--] engagements "👍🏼 * AGNAFIT BIDCO IS OFFERING SEK [---] PER SOBI SHARE WHICH VALUES ISSUED SHARE CAPITAL OF SOBI AT APPROXIMATELY SEK [----] BILLION * BOARD OF DIRECTORS OF SWEDISH ORPHAN BIOVITRUM AB UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS OF SWEDISH ORPHAN BIOVITRUM $SOBI Now its look like is too late for the train 🚂 $SOBI 👍🏼 Now its look like is too late for the train 🚂 $SOBI 👍🏼" [X Link](https://x.com/SenefLiveEvents/status/1433310339127463947) 2021-09-02T06:06Z [----] followers, [--] engagements "A lot of deal this month After yesterday Pfizer and Arena today CSL and Vifor whos next 🤔 $PFE $ARNA $CSL $VIFN $BMY $AUPH #biotech #BigPharma Australia's CSL makes $11.7 billion cash offer for Switzerland's Vifor Pharma https://t.co/DdyxwMYPBb Australia's CSL makes $11.7 billion cash offer for Switzerland's Vifor Pharma https://t.co/DdyxwMYPBb" [X Link](https://x.com/SenefLiveEvents/status/1470648384981770249) 2021-12-14T06:54Z [----] followers, [--] engagements "Sounds good 👍🏼 #idorsia $IDIA $IDRSF - Idorsia: The Foundation Is In Place And The Co. Is Ready For Great Success In [----]. https://t.co/6ZLvZOPsnH #stocks #trading #investing $IDRSF - Idorsia: The Foundation Is In Place And The Co. Is Ready For Great Success In [----]. https://t.co/6ZLvZOPsnH #stocks #trading #investing" [X Link](https://x.com/SenefLiveEvents/status/1610214158057832448) 2023-01-03T09:59Z [----] followers, [---] engagements "Very good news for Aurinia whats the next move #biotech $AUPH $OTSK $BMY $GSK $AUPH - Aurinia shares jump 36% on patent challenge settlement with India's Sun Pharma https://t.co/8lAnLUdUZD $AUPH - Aurinia shares jump 36% on patent challenge settlement with India's Sun Pharma https://t.co/8lAnLUdUZD" [X Link](https://x.com/SenefLiveEvents/status/1610286930293391360) 2023-01-03T14:48Z [----] followers, [---] engagements "Big Pharma want the big deal 😉 Who will be the Winner $AUPH $TGTX $AXSM $AMLX #biotech $NVS $PFE $MRK 🤔🎯 my actual favorite is @AuriniaPharma or maybe @TGTherapeutics 🙏🏼 https://www.wsj.com/articles/pfizer-novartis-merck-executives-say-they-are-hunting-for-deals-again-11675907783 https://www.wsj.com/articles/pfizer-novartis-merck-executives-say-they-are-hunting-for-deals-again-11675907783" [X Link](https://x.com/SenefLiveEvents/status/1623683154497228801) 2023-02-09T14:00Z [----] followers, [----] engagements "Mmm who Will be the buyer for $APLS 🤔 #biotech #bigpharma $BMY $NVS $MRK $JNJ" [X Link](https://x.com/SenefLiveEvents/status/1642627785553326081) 2023-04-02T20:39Z [----] followers, [---] engagements "Mmmm $AUPH Scripts growth so fast 🤔 do you see last candle 🚀 last call Who will be the Winner 🎰 $BMY $AZN $NVS $BIIB $JNJ $XBI $IBB #BigPharma #biotech" [X Link](https://x.com/SenefLiveEvents/status/1644343877690613761) 2023-04-07T14:18Z [----] followers, [----] engagements "@TomSilver39 Totally absurd because all the analysts projected sales at 1-2B in 2019-2020 TP-30 to [--] and today we have not even reached 1/4 in the salesthe company must be sold as soon as possible to execute its potential $AUPH $XBI $NVS $BMY #biotech" [X Link](https://x.com/SenefLiveEvents/status/1661808455030636560) 2023-06-25T11:31Z [----] followers, [---] engagements "Its time to to take the train at the right time for Seres. Named to Time [---] most influential companies 💪🏼 who will be the Winners Look like Nestle no or maybe $JNJ 🤔 $NESN $MCRB #biotech #time100" [X Link](https://x.com/SenefLiveEvents/status/1671556169473703938) 2023-06-21T16:30Z [----] followers, [---] engagements "@TomSilver39 Look like $ABBV will be the dark horse for $AUPH 🤔" [X Link](https://x.com/SenefLiveEvents/status/1691899420806185262) 2023-08-16T19:47Z [----] followers, [---] engagements "@unemon1 What about $BMY I dont see $NVS for $AUPH 🤔 and why $VRTX" [X Link](https://x.com/SenefLiveEvents/status/1699468451964760422) 2023-09-06T17:03Z [----] followers, [---] engagements "Recovery mode ON for $AUPH look like its the last call Whats your target price for a buyout $BMY $NVS $ROG $VRTX $GSK $AZN #biotech" [X Link](https://x.com/SenefLiveEvents/status/1699791627181805795) 2023-09-07T14:27Z [----] followers, [---] engagements "Roche is looking for big acquisitions Would Aurinia be a good candidate $AUPH $ROG $NVS $BMY $GSK $AZH $JNJ $VRTX #biotech #buyout" [X Link](https://x.com/SenefLiveEvents/status/1701170983388708935) 2023-09-11T09:49Z [----] followers, [---] engagements "@unemon1 @AuriniaPharma Look like something is cooking 🧑🍳 🤔 $AUPH $ABBV $BMY $AZN" [X Link](https://x.com/SenefLiveEvents/status/1704550836246811007) 2023-09-20T17:39Z [----] followers, [---] engagements "Hey @unemon1 whats your opinion about that - $AUPH $BMY $ABBV $JNJ $PFE $AZN $HEPA #biotech #buyout M&A" [X Link](https://x.com/SenefLiveEvents/status/1704830219037667736) 2023-09-21T12:09Z [----] followers, [---] engagements "Big volume for Mirati without any news 🤔 no news about the new management 🧑🍳 Fastening your seat belts is just the beginning 🚀 $MRTX $AZB $BMY $BAYER $LLY $PFE $ROG Looks like something is cooking 🤔 $MRTX #biotech Looks like something is cooking 🤔 $MRTX #biotech" [X Link](https://x.com/SenefLiveEvents/status/1704927703764271128) 2023-09-21T18:36Z [----] followers, [----] engagements "Very good opportunity to buy a position in Kindred group - The next earnings with an update on strategic review are on 29th Nov make your bet 🎰 $kind $mgm $ent $fltr #tech #gambling $Kind - Opened a long position (25 %) in Kindred Group as the stock trade pretty cheap - Will add more shares at SEK [--] https://t.co/WxKPLz6AHJ $Kind - Opened a long position (25 %) in Kindred Group as the stock trade pretty cheap - Will add more shares at SEK [--] https://t.co/WxKPLz6AHJ" [X Link](https://x.com/SenefLiveEvents/status/1713880637143130427) 2023-10-16T11:32Z [----] followers, [---] engagements "$CYTK - Cytokinetics surges amid report of takeover interest - Bloomberg Swiss company are mentioned for a potential bidder 🤔 $NVS or $ROG maybe $SNY #novartis #roche #sanofi" [X Link](https://x.com/SenefLiveEvents/status/1719408038648406312) 2023-10-31T17:36Z [----] followers, [---] engagements "@adamfeuerstein $SRPT will recover fast thats a very good opportunity to buy -🚀" [X Link](https://x.com/SenefLiveEvents/status/1719409028479001062) 2023-10-31T17:40Z [----] followers, [---] engagements "Another beat for the earnings 💪🏼 now its time to listen the conf call about the SR - $AUPH Q3 net product revenue $40.8M. 60% YoY. Achieved European pricing and reimbursement milestone triggering $10M payment from Otsuka. FY'23 net product revenue guidance range to $160" [X Link](https://x.com/SenefLiveEvents/status/1720021117132275772) 2023-11-02T10:12Z [----] followers, [---] engagements "Next one is Kindred group no A lot of similarity with GAN @puppyeh1 $KIND $GAN $MGM $ENT $FLTR $DKNG #iGames #tech $GAN taken out at $1.97 by Sega Sammy about a 80% premium versus when this thread went out. Thanks for playing 🙏🏻 https://t.co/O91G64c7NO $GAN taken out at $1.97 by Sega Sammy about a 80% premium versus when this thread went out. Thanks for playing 🙏🏻 https://t.co/O91G64c7NO" [X Link](https://x.com/SenefLiveEvents/status/1722173948488528258) 2023-11-08T08:47Z [----] followers, [----] engagements "A lot of interest for M&A in the gambling sector $KIND (Kindred group) its my favorite for the moment $888 $DKNG $FLTR $ENT $EVO [---] rejected a 700m takeover from Playtech in July $KIND $BETS $KAMBI https://t.co/7ZihM4b4qP [---] rejected a 700m takeover from Playtech in July $KIND $BETS $KAMBI https://t.co/7ZihM4b4qP" [X Link](https://x.com/SenefLiveEvents/status/1731940816317255737) 2023-12-05T07:37Z [----] followers, [---] engagements "True story and nice Analysis of Aurinia by @unemon1 $Auph between hands of the BP sales will be now around 0.8-1B place your bets now 🎰 its the last call before the train leaves the station $GSK $GILD $JNJ $SNY $NVS #biotech $AUPH . hard to see how LUPKYNIS in the hands of GSK won't be a 1b+ DRUG a year Used safes Assumptions: [--]. 35% of SLE Patients develop LN (GSK states 40% on it's website) [--]. LUPKYNIS costs double Benlysta (in reality it's more) Not surprised if this is JPM model used https://t.co/J4PZjw3YWl $AUPH . hard to see how LUPKYNIS in the hands of GSK won't be a 1b+ DRUG a year" [X Link](https://x.com/SenefLiveEvents/status/1732469532197843406) 2023-12-06T18:38Z [----] followers, [----] engagements "Its next $AUPH $BMY make two buyout in one month $KRTX & today $RYZB - $ABBV also two buyout $IMGN & $CERE lets go $GSK & $JNJ make it happen :) #biotech" [X Link](https://x.com/SenefLiveEvents/status/1739639142873436176) 2023-12-26T13:27Z [----] followers, [---] engagements "Mmm Cytokinetics $CYTK remind me the same tragic story with Aurinia $AUPH 🤔 #biotech $NVS $BMY $JNJ #buyout" [X Link](https://x.com/SenefLiveEvents/status/1744775247918694570) 2024-01-09T17:36Z [----] followers, [----] engagements "Same story repetition with Cytokinetics 🤔 $CYTK $MRTX #biotech $MRK Looks like something is cooking 🤔 $MRTX #biotech Looks like something is cooking 🤔 $MRTX #biotech" [X Link](https://x.com/SenefLiveEvents/status/1754194356611772621) 2024-02-04T17:25Z [----] followers, [----] engagements "Drug maker Novartis is in advanced talks to acquire MorphoSys a developer of cancer treatments that has a market value of [---] billion euros two people familiar with the matter said on Monday Novartis has so far prevailed over rival drug maker Incyte $mor $nvs $mor.de $incy" [X Link](https://x.com/SenefLiveEvents/status/1754542986547929153) 2024-02-05T16:30Z [----] followers, [---] engagements "@apefathers16060 The main ticker is in Germany $MOR.DE and its close at [-----] today the ticker in US its an ADR If we see [--] in Germany the stock in us will be around 22-23$ $MOR $NVS $INCY" [X Link](https://x.com/SenefLiveEvents/status/1754559366793920934) 2024-02-05T17:35Z [----] followers, [---] engagements "Deal done Novartis buy MorphoSys for [--] per share $NVS $NOVN $MOR $MOR.DE Cam novartis buy incyte in the future 🤔 $INCY Drug maker Novartis is in advanced talks to acquire MorphoSys a developer of cancer treatments that has a market value of [---] billion euros two people familiar with the matter said on Monday Novartis has so far prevailed over rival drug maker Incyte $mor $nvs $mor.de $incy Drug maker Novartis is in advanced talks to acquire MorphoSys a developer of cancer treatments that has a market value of [---] billion euros two people familiar with the matter said on Monday Novartis has" [X Link](https://x.com/SenefLiveEvents/status/1754631275573395508) 2024-02-05T22:21Z [----] followers, [---] engagements "MorphoSys Spokesperson Says "This Story Is Factually Wrong" In An Emailed Statement To Bloomberg News In Response To STAT News' Adam Feuerstein Article Entitled "Why Novartis Is Going To Walk Away From Its Acquisition" Whats happen @adamfeuerstein Fake News $NVS $MOR $INCY" [X Link](https://x.com/SenefLiveEvents/status/1754952125472207347) 2024-02-06T19:36Z [----] followers, [---] engagements "Last run or end of run for Aurinia Tonight the earnings of Gilead after hours Rumored for potential buyer $GILD Earnings of $AUPH are scheduled for the [--] Feb. with company update on the same day earnings of Otsuka Place your bets no more bets 🎰 $XBI $NVS $AZN $SNY" [X Link](https://x.com/SenefLiveEvents/status/1754959627249152136) 2024-02-06T20:05Z [----] followers, [---] engagements "Shopping Time 🙃 What you buy today $XBI $SPY $BCYC & $SWTX or $CYTK maybe $AUPH Or the big player $AMZN $TSLA $NVDA" [X Link](https://x.com/SenefLiveEvents/status/1757413709423464622) 2024-02-13T14:37Z [----] followers, [---] engagements "Very disappointed by @AuriniaPharma $AUPH I lose a ton of money Icant believe the SR end with no formal Bid Whats the problem with the company We need to know the truth How much are the bid Need a EGM @TonKhalife @unemon1 $XBI $BMY $NVS $GILD $OTSKY" [X Link](https://x.com/SenefLiveEvents/status/1758152980379922828) 2024-02-15T15:35Z [----] followers, [----] engagements "Viking $VKTX its probably the next big candidate for a buyout we will se $80 before end of year - $JNJ $PFE $SNY Leerink:' $VKTX VENTURE Data Shows 13% Pbo-Adj Weight Loss for SC '2735; Clear Win for VKTX." https://t.co/GiG8pW7nU7 Leerink:' $VKTX VENTURE Data Shows 13% Pbo-Adj Weight Loss for SC '2735; Clear Win for VKTX." https://t.co/GiG8pW7nU7" [X Link](https://x.com/SenefLiveEvents/status/1762500711995331000) 2024-02-27T15:31Z [----] followers, [---] engagements "Finally Idorsia is back on the game 💪🏼 $IDIA $VTRS $JNJ #biotech We are very proud to announce today that the US FDA has approved our drug for the treatment of high blood pressure in combination with other antihypertensives. Read more: https://t.co/1Wdae9od63 https://t.co/l4hBBRpk29 We are very proud to announce today that the US FDA has approved our drug for the treatment of high blood pressure in combination with other antihypertensives. Read more: https://t.co/1Wdae9od63 https://t.co/l4hBBRpk29" [X Link](https://x.com/SenefLiveEvents/status/1770337815668142569) 2024-03-20T06:33Z [----] followers, [---] engagements "I probably have find the next Super Micro $SMCI - Keep an eye on $SMTC Baird adds Se tech to the fresh picks list Baird said the semiconductor manufacturer is a hidden AI gem. $NVDA $AMD $INTC $DELL #semiconductors" [X Link](https://x.com/SenefLiveEvents/status/1773052158956405028) 2024-03-27T18:19Z [----] followers, [---] engagements "Not bad for Semtech $SMTC - Net sales of $192.9 million above the midpoint of guidance [--] GAAP gross margin of (0.2)% and Non-GAAP gross margin of 48.9% above the midpoint of guidance - Positive operating cash flow of $13.9 million and free cash flow of $12.2 million $SMCI $SPY I probably have find the next Super Micro $SMCI - Keep an eye on $SMTC Baird adds Se tech to the fresh picks list Baird said the semiconductor manufacturer is a hidden AI gem. $NVDA $AMD $INTC $DELL #semiconductors I probably have find the next Super Micro $SMCI - Keep an eye on $SMTC Baird adds Se tech to the fresh" [X Link](https://x.com/SenefLiveEvents/status/1773449144855609751) 2024-03-28T20:36Z [----] followers, [---] engagements "Skynet on the way 🤔 Microsoft $MSFT opens new tab and OpenAI are working on plans for a data center project that could cost as much as $100 billion and include an artificial intelligence supercomputer called "Stargate" set to launch in [----] $NVDA #OpenAI https://www.reuters.com/technology/microsoft-openai-planning-100-billion-data-center-project-information-reports-2024-03-29/ https://www.reuters.com/technology/microsoft-openai-planning-100-billion-data-center-project-information-reports-2024-03-29/" [X Link](https://x.com/SenefLiveEvents/status/1774996415892127929) 2024-04-02T03:04Z [----] followers, [---] engagements "Look Peter takes notes before the end $AUPH $VRTX acquire $ALPN whos traded a 6$ at the 52week lows $XBI Vertex $VRTX enters into an agreement to ACQUIRE Alpine Immune Sciences $ALPN for $65 per share or about $4.9 billion in cash. Vertex $VRTX enters into an agreement to ACQUIRE Alpine Immune Sciences $ALPN for $65 per share or about $4.9 billion in cash" [X Link](https://x.com/SenefLiveEvents/status/1778154742297870480) 2024-04-10T20:15Z [----] followers, [----] engagements "Comme of $JPM for $DAWN - With a clean label and early approval of Ojemda in r/r pLGG we see DAWN shares moving into the high-teens to low-$20s / share level" reit their OW and $36 PT #biotech $DAWN PR. OJEMDA Receives FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) the Most Common Form of Childhood Brain Tumor. https://t.co/uOkAGgRYhV $DAWN PR. OJEMDA Receives FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) the Most Common Form of Childhood Brain Tumor. https://t.co/uOkAGgRYhV" [X Link](https://x.com/SenefLiveEvents/status/1782862998073225562) 2024-04-23T20:03Z [----] followers, [---] engagements "Back in Seres $MCRB earnings are in two days I see a lot of strength in the vol the past month Seres is eligible to receive of Nestl payments of up to $225 million for the achievement of specified net sales milestones $XBI $NSRGY $NESN Now look good for Seres $MCRB 🤔 Nestle confirm the sells of peanut allergy business to stallergenes $NSRGY $NESN #biotech https://t.co/VeEftkRVk2 Now look good for Seres $MCRB 🤔 Nestle confirm the sells of peanut allergy business to stallergenes $NSRGY $NESN #biotech https://t.co/VeEftkRVk2" [X Link](https://x.com/SenefLiveEvents/status/1787541011528368419) 2024-05-06T17:52Z [----] followers, [----] engagements "Vote are done with a withhold for all Aurinia 👍🏼 you have [--] days left Peter Enjoy $AUPH $XBI $PFE $NVS $BMY $SNY" [X Link](https://x.com/SenefLiveEvents/status/1790655298094432353) 2024-05-15T08:07Z [----] followers, [----] engagements "Whats the conditions of the deal with Nestl for Seres Memorandum not an final agreement no PR of Nestle 🤔 Looks a good entry today $MCRB $NSRGY $NESN #biotech https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-enters-memorandum-understanding-vowsttm-asset Very good analysis 👍🏼 $MCRB @Jad121212 https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-enters-memorandum-understanding-vowsttm-asset Very good analysis 👍🏼 $MCRB @Jad121212" [X Link](https://x.com/SenefLiveEvents/status/1798713016248303742) 2024-06-06T13:46Z [----] followers, [----] engagements "I see a good opportunity at this level for Seres 😉 $MCRB $NESN $NSRGY $LLY #biotech Whats the conditions of the deal with Nestl for Seres Memorandum not an final agreement no PR of Nestle 🤔 Looks a good entry today $MCRB $NSRGY $NESN #biotech https://t.co/QbvVSFwu7i Whats the conditions of the deal with Nestl for Seres Memorandum not an final agreement no PR of Nestle 🤔 Looks a good entry today $MCRB $NSRGY $NESN #biotech https://t.co/QbvVSFwu7i" [X Link](https://x.com/SenefLiveEvents/status/1799154843103170904) 2024-06-07T19:01Z [----] followers, [---] engagements "Congrats to all the shareholders 👏🏼 We won AGM the best is yet to come 🚀 Bye Peter $AUPH $XBI $PFE $BMY $NVS $SNY https://www.auriniapharma.com/investors-and-media/news-events/press-releases/detail/330/aurinia-announces-2024-annual-general-meeting-results Vote are done with a withhold for all Aurinia 👍🏼 you have [--] days left Peter Enjoy $AUPH $XBI $PFE $NVS $BMY $SNY https://t.co/UG5uQUdJCB https://www.auriniapharma.com/investors-and-media/news-events/press-releases/detail/330/aurinia-announces-2024-annual-general-meeting-results Vote are done with a withhold for all Aurinia 👍🏼 you" [X Link](https://x.com/SenefLiveEvents/status/1801665791571726685) 2024-06-14T17:19Z [----] followers, [---] engagements "The move of today are very strangefor hubspot $HUBS $GOOG Google its not the only one interested (betavile article) maybe $MSFT or something others still in #bigtech #tech #cloud #cmr $HUBS Google Reportedly Shelving Bid; Creates Buying Opportunity - RBC PT $700 $HUBS Google Reportedly Shelving Bid; Creates Buying Opportunity - RBC PT $700" [X Link](https://x.com/SenefLiveEvents/status/1811135111301087387) 2024-07-10T20:27Z [----] followers, [---] engagements "Look like something is cooking with Seres $MCRB $NSRGY $NESN $MRK $SNY #biotech $MCRB This MOU was PRd to global markets to let large pharma know theyre for sale I have no doubt of it now. Float will be all banks and funds by September its being swallowed up $MCRB This MOU was PRd to global markets to let large pharma know theyre for sale I have no doubt of it now. Float will be all banks and funds by September its being swallowed up" [X Link](https://x.com/SenefLiveEvents/status/1811135784973668588) 2024-07-10T20:29Z [----] followers, [----] engagements "What an opportunity at this price for Seres if the results of Ser-155 are good we can see easy a 100-150% run Any update about rumors of Nestl $MCRB $NSRGY $NESN $MRK $SNY Look like something is cooking with Seres $MCRB $NSRGY $NESN $MRK $SNY #biotech Look like something is cooking with Seres $MCRB $NSRGY $NESN $MRK $SNY #biotech" [X Link](https://x.com/SenefLiveEvents/status/1833563043420377488) 2024-09-10T17:47Z [----] followers, [----] engagements "@solferglc @said_boussalem This is a projection of analyses unfortunately I did not understand the downward movement after excellent results $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1834462067413139693) 2024-09-13T05:20Z [----] followers, [---] engagements "@bio_clouseau @monaco_biotech Aurinia are more better VOC works in [--] months hence [--] weeks to provide sustained complete renal response in twice as many patients as placebo versus Roches drug at [--] weeks clearly VOC is far superior $AUPH" [X Link](https://x.com/SenefLiveEvents/status/1839245448076279819) 2024-09-26T10:07Z [----] followers, [---] engagements "That would be a good candidate for Shopify $SHOP $LSPD Exclusive: Canadian payments software firm Lightspeed explores sale sources say @MilanaVinn $LSPD https://t.co/QtV6CNEEuW Exclusive: Canadian payments software firm Lightspeed explores sale sources say @MilanaVinn $LSPD https://t.co/QtV6CNEEuW" [X Link](https://x.com/SenefLiveEvents/status/1839251550738194606) 2024-09-26T10:31Z [----] followers, [---] engagements "Why the price its in this level🤔 Company is undervalued soon the deal is closed and Ser-155 go to fast track FDA Nestle backup the company till 2025💪🏼 and and it becomes soon the big investor with a board seat Its time to play big Im adding today $MCRB $NSRGY $MRK $SNY $NOVO What an opportunity at this price for Seres if the results of Ser-155 are good we can see easy a 100-150% run Any update about rumors of Nestl $MCRB $NSRGY $NESN $MRK $SNY What an opportunity at this price for Seres if the results of Ser-155 are good we can see easy a 100-150% run Any update about rumors of Nestl $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1839345950357364822) 2024-09-26T16:47Z [----] followers, [----] engagements "Welcome back Seres 🚀 What a come back from the hellWhy nestle didn't do PR for the closing of the vowst I hope good news coming soon 🙏🏼 $MCRB $NSRGY $NESN $MRK $SNY $NOVO #biotech Why the price its in this level🤔 Company is undervalued soon the deal is closed and Ser-155 go to fast track FDA Nestle backup the company till 2025💪🏼 and and it becomes soon the big investor with a board seat Its time to play big Im adding today $MCRB $NSRGY $MRK $SNY $NOVO Why the price its in this level🤔 Company is undervalued soon the deal is closed and Ser-155 go to fast track FDA Nestle backup the" [X Link](https://x.com/SenefLiveEvents/status/1841208393018826826) 2024-10-01T20:07Z [----] followers, [----] engagements "Thats a little bit story about Nestle and Aimmune a lot of similarities with Seres $MCRB : NHSc currently has a total investment in Aimmune of USD473 million an approximate 25.6% equity ownership stake. Around 19.6% is voting common stock and the balance non-voting preferred" [X Link](https://x.com/SenefLiveEvents/status/1849786016514638198) 2024-10-25T12:12Z [----] followers, [---] engagements "stock. NHSc made its initial investment of USD145 million in Aimmune in November [----] followed by further investments of USD30 million in February [----] USD98 million in November [----] and USD200 million in January [----]. Nestl S.A.s acquired Aimmune for 34.50$ $NSRGY #biotech" [X Link](https://x.com/SenefLiveEvents/status/1849786019324801217) 2024-10-25T12:12Z [----] followers, [---] engagements "Next stock market crash is coming this year or in [----] #market #finance $BAC $JPM $UBS $MS $WFC $C #bank" [X Link](https://x.com/SenefLiveEvents/status/1851722308081324401) 2024-10-30T20:26Z [----] followers, [---] engagements "Still no date for the earnings of Seres $MCRB why this silence Pending news We need a CEO like Viking with a transparent communication $VKTX #biotech no communication about the deal Vowst by Nestle $NSRGY Hey @SeresTX when its the earnings $MCRB Hey @SeresTX when its the earnings $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1853856609958871150) 2024-11-05T17:47Z [----] followers, [----] engagements "We have engaged MTS Health Partners to facilitate the processProcess of what 🤔 The JPM analyst asked about this and Eric's response was that it could happen very quickly and then that there was no need for partnership.it's a lying poker game $MCRB $NSRGY $MRK $SNY $PFE #bio Look good for a company with a market cap of 113M : Seres is actively seeking a partner to provide financial resources and other capabilities to support the Companys goal SER-155 clinical trial showed 77% reduction in bloodstream infections Received $175M from VOWS $MCRB $NSRG Look good for a company with a market cap of" [X Link](https://x.com/SenefLiveEvents/status/1856783985663475780) 2024-11-13T19:39Z [----] followers, [---] engagements "$ALKS $DVA $JBL $RL - Alkermes DaVita Jabil Ralph Lauren among potential M&A candidates - BofA $BAC" [X Link](https://x.com/SenefLiveEvents/status/1858567455620428258) 2024-11-18T17:46Z [----] followers, [---] engagements "We are at 100M mkt So far Nestle has invested around 850M since [----] with the first partnership and the Vowst without the milestones Do you really believe that they will not go further $MCRB $NSRGY $MRK $PFE $JNJ Look good for a company with a market cap of 113M : Seres is actively seeking a partner to provide financial resources and other capabilities to support the Companys goal SER-155 clinical trial showed 77% reduction in bloodstream infections Received $175M from VOWS $MCRB $NSRG Look good for a company with a market cap of 113M : Seres is actively seeking a partner to provide financial" [X Link](https://x.com/SenefLiveEvents/status/1858568070656065802) 2024-11-18T17:48Z [----] followers, [----] engagements "BridgeBio Its a life savior and a big target for Big Pharma $BBIO $PFE $JNJ $NVS $ROG $MRK $BBIO "To honor the courage of our U.S. clinical trial participants BridgeBio will provide these patients Attruby free for life" nice to see $BBIO "To honor the courage of our U.S. clinical trial participants BridgeBio will provide these patients Attruby free for life" nice to see" [X Link](https://x.com/SenefLiveEvents/status/1860243939632009322) 2024-11-23T08:48Z [----] followers, [----] engagements "Lets go Seres its time to shine 77% relative risk reduction in bacterial bloodstream infections versus placebo Whats the next step Fast track partnership 🤔 $MCRB $NSRGY $NVS $MRK $JNJ FDA Grants Breakthrough Therapy Designation to Seres Therapeutics SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) $MCRB https://t.co/JCUuQli4MN FDA Grants Breakthrough Therapy Designation to Seres Therapeutics SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant" [X Link](https://x.com/SenefLiveEvents/status/1866094759481090227) 2024-12-09T12:17Z [----] followers, [----] engagements "Very interesting presentation for Seres - good opportunity again today😉 $MCRB $NSRGY $JNJ $LLY #Nestle #biotech https://ir.serestherapeutics.com/node/12291/html Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates $MCRB https://t.co/4mwMUTlL5C https://ir.serestherapeutics.com/node/12291/html Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates $MCRB https://t.co/4mwMUTlL5C" [X Link](https://x.com/SenefLiveEvents/status/1878828639627985099) 2025-01-13T15:37Z [----] followers, [----] engagements "@faststocknewss SpringWorks Therapeutics: FDA approves mirdametinib for adult and pediatric patients with neurofibromatosis type [--] who have symptomatic plexiform neurofibromas not amenable to complete resection $SWTX $MRK" [X Link](https://x.com/SenefLiveEvents/status/1889416382774722580) 2025-02-11T20:49Z [----] followers, [---] engagements "Step by step Seres Everything looks good for a success story with the FDA Who will be the partner or the buyer 🤔 $MCRB $MRK $JNJ $GSK $PFE $NSRGY #nestle Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach $MCRB https://t.co/HZnXq9MPK3 Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach $MCRB https://t.co/HZnXq9MPK3" [X Link](https://x.com/SenefLiveEvents/status/1896547498128547960) 2025-03-03T13:05Z [----] followers, [---] engagements "Traded last year at 0.88$ $CMRX $JAZZ $MCRB $JAZZ to Acquire $CMRX for $8.55 per share $JAZZ to Acquire $CMRX for $8.55 per share" [X Link](https://x.com/SenefLiveEvents/status/1897274701950672925) 2025-03-05T13:15Z [----] followers, [---] engagements "You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for Seres. the die is cast in my opinion $MCRB $NSRGY $MRK $JNJ $NVS #Biotech $MCRB Seres Therapeutics reports FY24 EPS (81c) consensus (20c) "We have made significant progress advancing SER-155 as a novel live biotherapeutic candidate designed to prevent life-threatening bloodstream infections in allo-HSCT recipients" said Eric Shaff President and $MCRB Seres Therapeutics reports FY24 EPS (81c) consensus (20c) "We have" [X Link](https://x.com/SenefLiveEvents/status/1900206975587090556) 2025-03-13T15:27Z [----] followers, [----] engagements "Did you buy Incyte at this level $incy $nvs $mrk #biotech $xbi $ibb" [X Link](https://x.com/SenefLiveEvents/status/1900534563048219092) 2025-03-14T13:08Z [----] followers, [---] engagements "I regret not having buy some yesterday let's go Seres & come on Nestl $MCRB $TGTX $NSRGY $NVS $MRK $JNJ #biotech $xbi $ibb You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for Seres. the die is cast in my opinion $MCRB $NSRGY $MRK $JNJ $NVS #Biotech You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for Seres. the die is cast in my opinion $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1900594466152411606) 2025-03-14T17:06Z [----] followers, [---] engagements "All Pharma & Biotech sector waiting on this tariffs to make the deal happen💰🍀 $xbi $ibb $jnj $mrk $lly $nvs $azn #biotech #pharma JUST IN: President Trump is set to announce new pharmaceutical tariffs JUST IN: President Trump is set to announce new pharmaceutical tariffs" [X Link](https://x.com/SenefLiveEvents/status/1905723891395526915) 2025-03-28T20:49Z [----] followers, [---] engagements "To all Seres shareholders I recommend that you vote no to all the proposals. The board and management have brought no added value apart from a terrible fall in the share price. $MCRB $NSRGY #biotech #Nestle" [X Link](https://x.com/SenefLiveEvents/status/1907516562438816011) 2025-04-02T19:32Z [----] followers, [----] engagements "The future looks bright and I'm sure that with the appointment of Dr. Woerle the company is at a turning point. Together we can make a difference. All the best" [X Link](https://x.com/SenefLiveEvents/status/1907516568516296921) 2025-04-02T19:32Z [----] followers, [---] engagements "Tariffs of the Pharmaceutical products will not be subject to reciprocal tariffs for now Seres Therapeutics not concerned $MCRB #tariffs #biotech $NESN.SW" [X Link](https://x.com/SenefLiveEvents/status/1907655267090604434) 2025-04-03T04:43Z [----] followers, [---] engagements "Whats the news Seres Why any PR after the vote and the filling of RS yesterday Its the last run or a deal done Who will be the partner Nestle again Merk 🤔 $MCRB $NSRGY $MRK #biotech Dont miss to vote Last call Management as failed No value for shareholders of Seres I hope Nestle will be on the side of shareholders $MCRB $NSRGY $NESN.SW #biotech #pharma #tariffs Dont miss to vote Last call Management as failed No value for shareholders of Seres I hope Nestle will be on the side of shareholders $MCRB $NSRGY $NESN.SW #biotech #pharma #tariffs" [X Link](https://x.com/SenefLiveEvents/status/1912219008558068087) 2025-04-15T18:58Z [----] followers, [----] engagements "Before the buyout of Sigilon $SGTX a company owned by Flagship the same company behind Seres $MCRB There was a corporate split and the company was bought out a month later. Nestle's earnings are out this Thursday I hope we see big news coming $NSRGY $NESN.SW $LLY Whats the news Seres Why any PR after the vote and the filling of RS yesterday Its the last run or a deal done Who will be the partner Nestle again Merk 🤔 $MCRB $NSRGY $MRK #biotech Whats the news Seres Why any PR after the vote and the filling of RS yesterday Its the last run or a deal done Who will be the partner Nestle again Merk" [X Link](https://x.com/SenefLiveEvents/status/1914758740894736778) 2025-04-22T19:10Z [----] followers, [---] engagements "@PK_Fund I see more Roche $ROG to acquire TG Therapeutics $TGTX but Sanofi its a good scenario $SNY" [X Link](https://x.com/SenefLiveEvents/status/1915395253445550433) 2025-04-24T13:19Z [----] followers, [---] engagements "Good deal 7+7 👍🏼 $RGLS $NVS Soon Seres $MCRB $RGLS (halted pre) Regulus Therapeutics (RGLS) to be Acquired by Novartis $NVS for $7 Per Share - SI https://t.co/nPzHAsBXzH $RGLS (halted pre) Regulus Therapeutics (RGLS) to be Acquired by Novartis $NVS for $7 Per Share - SI https://t.co/nPzHAsBXzH" [X Link](https://x.com/SenefLiveEvents/status/1917536864841482702) 2025-04-30T11:09Z [----] followers, [---] engagements "$MCRB [--] Nov [----] We have engaged MTS Health Partners to facilitate the process Still nothing whats in going on we are in May Partnership Buyout 🤔 The latest rumors speak of an acquisition by Nestle. where there's smoke there's fire $NSRGY $JNJ $MRK $SGTX #biotech Seres Therapeutics Presents Data at the [----] Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases $MCRB https://t.co/1VfVETubGX Seres Therapeutics Presents Data at the [----] Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics" [X Link](https://x.com/SenefLiveEvents/status/1919454709351338060) 2025-05-05T18:10Z [----] followers, [---] engagements "Good deal for FootLocker 👍🏼 $FL $DKS $DKS confirms $FL deal $24 cash or $DKS stock $DKS confirms $FL deal $24 cash or $DKS stock" [X Link](https://x.com/SenefLiveEvents/status/1922956550588575772) 2025-05-15T10:05Z [----] followers, [---] engagements "Normally news about FDA or partnership a due for next week Seres Therapeutics we touched the low Its time to run now In the same time Nestl to create industry-leading capabilities in bio tech $MCRB $NSRGY $LLY $JNJ $NVS https://www.nestle.com/media/pressreleases/allpressreleases/bio-tech-deep-tech-research-development $MCRB Earnings Call Highlights. They have had frequent recent contact with the FDA about phase [--] study design for SER-155 in patients undergoing allo-HSCT. They expect to submit a final design for approval to the FDA in about [--] weeks. They did not want to disclose many" [X Link](https://x.com/SenefLiveEvents/status/1923020054548922729) 2025-05-15T14:18Z [----] followers, [---] engagements "The human microbiome market is projected to expand at a CAGR of 20.42% growing from $941.215 million in [----] to $2.38 billion by [----]. $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1937180368366694655) 2025-06-23T16:06Z [----] followers, [---] engagements "Soon a similar scenario with Seres therapeutics like Nektar therapeutics 🧪 $NKTR $MCRB #biotech The human microbiome market is projected to expand at a CAGR of 20.42% growing from $941.215 million in [----] to $2.38 billion by [----]. $MCRB The human microbiome market is projected to expand at a CAGR of 20.42% growing from $941.215 million in [----] to $2.38 billion by [----]. $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1937590515291099330) 2025-06-24T19:15Z [----] followers, [---] engagements "@Investingcom Seres Therapeutics $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1941788987061924137) 2025-07-06T09:19Z [----] followers, [---] engagements "Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB $MRK to acquire $VRNA for $107/ADS https://t.co/qtlcVzmXxz $MRK to acquire $VRNA for $107/ADS https://t.co/qtlcVzmXxz" [X Link](https://x.com/SenefLiveEvents/status/1942896814358777952) 2025-07-09T10:41Z [----] followers, [---] engagements "$MCRB Seres Therapeutics run a 100% in one month Thats smells good no $MRK $NVS $NSRGY $JNJ Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1945713636820898241) 2025-07-17T05:14Z [----] followers, [---] engagements "Eric step down for one reason if now the future and know it will be not part of the planEngagements with several parties are underway regarding various deal structures including potential business development and partnership opportunities for Seres Therapeutics $MCRB $NSRGY Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1947665414038950111) 2025-07-22T14:29Z [----] followers, [---] engagements "@Biotech2k1 $MCRB 🚀" [X Link](https://x.com/SenefLiveEvents/status/1949203816244482254) 2025-07-26T20:22Z [----] followers, [--] engagements "Whats happen with the milestones payment of Nestl Last week communicate are very interesting - Engagements with several parties are underway regarding various deal structures including potential business development and partnership opportunities $MCRB Eric step down for one reason if now the future and know it will be not part of the planEngagements with several parties are underway regarding various deal structures including potential business development and partnership opportunities for Seres Therapeutics $MCRB $NSRGY Eric step down for one reason if now the future and know it will be not" [X Link](https://x.com/SenefLiveEvents/status/1950209613418127865) 2025-07-29T14:59Z [----] followers, [---] engagements "If you dont know Seres Therapeutics read this article whos explain the real gems 💎 After the announcement of the last week. Think that are on the final talks for something big Its your last chance to be part of the last train 🚂 $MCRB $NSRGY https://seekingalpha.com/article/4805623-serestherapeutics-speculative-gem-backed-by-ser155-fda-breakthrough https://seekingalpha.com/article/4805623-serestherapeutics-speculative-gem-backed-by-ser155-fda-breakthrough" [X Link](https://x.com/SenefLiveEvents/status/1950817141541749035) 2025-07-31T07:13Z [----] followers, [---] engagements "Maybe next Bo will be Okta $okta $comm Amphenol $APH is nearing a deal to buy CommScope Holdings $COMM broadband connectivity and cable unit The deal would be valued at roughly $10.5 billion including debt - WSJ Amphenol $APH is nearing a deal to buy CommScope Holdings $COMM broadband connectivity and cable unit The deal would be valued at roughly $10.5 billion including debt - WSJ" [X Link](https://x.com/SenefLiveEvents/status/1952310706394587339) 2025-08-04T10:08Z [----] followers, [---] engagements "Tomorrow its 6th August [----] and thats marks one year of the agreement of The deal with Nestle & Seres therapeutics published on the 6th August 2024Its time to close the chapter on the earning 🚀 $MCRB $NSRGY https://www.nestlehealthscience.com/newsroom/press-releases/nhs-agreement-vowst-global-rights https://www.nestlehealthscience.com/newsroom/press-releases/nhs-agreement-vowst-global-rights" [X Link](https://x.com/SenefLiveEvents/status/1952760910033871304) 2025-08-05T15:57Z [----] followers, [---] engagements "$ZVRA Zevra Therapeutics its a Bo candidate $BIIB $AMGN Sources familiar with the situation say the company has had multiple approaches around $20. They have recruited advisors to auction to the highest bidder from both US and Europe. @ZaksTradersCafe https://zakstraderscafe.com/zevra-therapeutics-nasdaqzvra-multiple-approaches/12387/ https://zakstraderscafe.com/zevra-therapeutics-nasdaqzvra-multiple-approaches/12387/" [X Link](https://x.com/SenefLiveEvents/status/1952762987288076419) 2025-08-05T16:05Z [----] followers, [---] engagements "@whichwaygo @ZaksTradersCafe 😂 Lets see what happen my friend give him a chance no" [X Link](https://x.com/SenefLiveEvents/status/1952766714568949860) 2025-08-05T16:20Z [----] followers, [--] engagements "Mmmm Seres Therapeutics whats is this options calls of October mean 15$ buyer for a value of 800K last week and yesterday buyer of 17.5$ for a value of 600K $MCRB $NSRGY $UNH #biotech #microbiome #optionsalerts Tomorrow its 6th August [----] and thats marks one year of the agreement of The deal with Nestle & Seres therapeutics published on the 6th August 2024Its time to close the chapter on the earning 🚀 https://t.co/cb17bnsh8B $MCRB $NSRGY Tomorrow its 6th August [----] and thats marks one year of the agreement of The deal with Nestle & Seres therapeutics published on the 6th August 2024Its" [X Link](https://x.com/SenefLiveEvents/status/1956291909497848128) 2025-08-15T09:48Z [----] followers, [---] engagements "Finally Seres Therapeutics received offers of Nestl for 41$ + 35$ CVR reported by Swiss media @InsideParade & @awp_de thats look not bad :) Probably the last time to buy more $MCRB $NSRGY #biotech $xbi $ibb Make your own DD and you understand Since [----] Nestl Health Science has invested big in Seres Therapeutics: [----] $66.5M + $30M 💵 [----] $175M + $125M 📈 [----] $175M + $18M 🔄 [----] $50M + $25M 💰 Total so far: $664.5M Potential: +$275M milestones #biotech #Nestle $NSRGY $MCRB https://t.co/nc7juq8TvB Make your own DD and you understand Since [----] Nestl Health Science has invested big in Seres" [X Link](https://x.com/SenefLiveEvents/status/1964972004064530758) 2025-09-08T08:40Z [----] followers, [----] engagements "Another one Tourmaline $TRML 48$ for Novartis $NVS good bye $RNA $XBI $IBB Novartis agrees to acquire Tourmaline Bio at an offer price of $48 per share in cash https://t.co/Q5EBFLMrRc Novartis agrees to acquire Tourmaline Bio at an offer price of $48 per share in cash https://t.co/Q5EBFLMrRc" [X Link](https://x.com/SenefLiveEvents/status/1965289674773279063) 2025-09-09T05:42Z [----] followers, [----] engagements "@monaco_biotech Have some problems with Seres Therapeutics $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1966664790291394767) 2025-09-13T00:46Z [----] followers, [---] engagements "@monaco_biotech Seres therapeutics $MCRB" [X Link](https://x.com/SenefLiveEvents/status/1966707185741660577) 2025-09-13T03:35Z [----] followers, [---] engagements "the Sept [--] Nestl $41/share bid before settling lower. $NSRGY #biotech $xbi $ibb Outperformed the biotech sector dramatically. Trend phases: Light green zone = sustained uptrend Light gray zone = consolidation Salmon zone = September spike on Nestl news" [X Link](https://x.com/SenefLiveEvents/status/1966718207915434023) 2025-09-13T04:18Z [----] followers, [---] engagements "Its time to add more Zevra - $150M+in cash two FDA approved drugs including one for a rare disease $ZVRA #biotech $ZVRA Insider Purchase: Director at $ZVRA Buys [-----] Shares - Quiver Quantitative #stocks #news https://t.co/wyqOzEIxps $ZVRA Insider Purchase: Director at $ZVRA Buys [-----] Shares - Quiver Quantitative #stocks #news https://t.co/wyqOzEIxps" [X Link](https://x.com/SenefLiveEvents/status/1967948098472489177) 2025-09-16T13:46Z [----] followers, [---] engagements "Damn its Oracle year a deal per week🚨 $ORCL $ORCL ORACLE IN TALKS WITH META ON $20B AI CLOUD COMPUTING DEAL $ORCL ORACLE IN TALKS WITH META ON $20B AI CLOUD COMPUTING DEAL" [X Link](https://x.com/SenefLiveEvents/status/1969131440391524443) 2025-09-19T20:08Z [----] followers, [--] engagements "PFIZER $PFE WILL PAY METSERA $MTSR $47.50 IN CASH A SHARE AND A FURTHER $22.50 IF CERTAIN PERFORMANCE MILESTONES ARE MET What about $VKTX valued at 10bn 🤷🏻♂ #biotech $xbi $ibb Pfizer is closing in on a potential $7.3 billion takeover of obesity startup Metsera the Financial Times reported citing unidentified people familiar with the matter https://t.co/5fMo7L3DaX Pfizer is closing in on a potential $7.3 billion takeover of obesity startup Metsera the Financial Times reported citing unidentified people familiar with the matter https://t.co/5fMo7L3DaX" [X Link](https://x.com/SenefLiveEvents/status/1969999724586717524) 2025-09-22T05:38Z [----] followers, [---] engagements "Intel its still a buy Whats your target for the next month $INTC $ORCL $NVDA $AMD #tech #fintech #trump Intel stock is up 50% over the last month putting U.S. stake at $16 billion https://t.co/xjBcFBYHFT Intel stock is up 50% over the last month putting U.S. stake at $16 billion https://t.co/xjBcFBYHFT" [X Link](https://x.com/SenefLiveEvents/status/1973806903856967989) 2025-10-02T17:46Z [----] followers, [---] engagements "OpenAI non profit but a lot of partnerships 🤔 #openai #grook $NVDA $ORCL $GOOG $MSFT $CORE $AVGO $META $AMZN This is wild: A map of OpenAI's recent partnerships. Now one of the largest companies in the world worth over $500B still owned by a non-profit parent. What's next https://t.co/P8ZuwpDFOb This is wild: A map of OpenAI's recent partnerships. Now one of the largest companies in the world worth over $500B still owned by a non-profit parent. What's next https://t.co/P8ZuwpDFOb" [X Link](https://x.com/SenefLiveEvents/status/1975946819713781780) 2025-10-08T15:30Z [----] followers, [---] engagements "$SHOP next target $165 🤔 https://x.com/ophirgottlieb/status/997145481800073216 $SHOP Shopify Stock: Next Stop $165 @themotleyfool https://t.co/sK4DLWWUps - "Two analysts jack up their price targets on the e-commerce platform provider after a developer conference presentation" https://x.com/ophirgottlieb/status/997145481800073216 $SHOP Shopify Stock: Next Stop $165 @themotleyfool https://t.co/sK4DLWWUps - "Two analysts jack up their price targets on the e-commerce platform provider after a developer conference presentation"" [X Link](https://x.com/SenefLiveEvents/status/997152304678793222) 2018-05-17T16:30Z [----] followers, [--] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
@SenefLiveEvents Senef AS
Senef AS posts on X about $mcrb, $nsrgy, $nvs, $mrk the most. They currently have [-----] followers and [---] posts still getting attention that total [--] engagements in the last [--] hours.
Engagements: [--] #
- [--] Week [-----] +367%
- [--] Month [-----] -61%
- [--] Months [------] +69%
- [--] Year [------] +13%
Mentions: [--] #
- [--] Month [--] -28%
- [--] Months [--] +100%
- [--] Year [---] +133%
Followers: [-----] #
- [--] Week [-----] -0.14%
- [--] Month [-----] -0.07%
- [--] Months [-----] -0.56%
- [--] Year [-----] -0.49%
CreatorRank: [---------] #
Social Influence
Social category influence stocks finance cryptocurrencies technology brands currencies countries social networks financial services travel destinations automotive brands
Social topic influence $mcrb, $nsrgy, $nvs, $mrk, $jnj #44, $xbi #53, $pfe, $auph, $ibb #15, $sny
Top accounts mentioned or mentioned by @monacobiotech @unemon1 @maximusholla @auriniapharma @bharringtonw11 @tomsilver39 @adamfeuerstein @zakstraderscafe @kaniel2909 @mroliverbarnes @jfkamerica @semodough @astrazeneca @seedy19tron @rnaianalyst @doepkemichel @apexonco @mwm76 @idorsia @deutschebank
Top assets mentioned Novartis AG (NVS) Merck & Co., Inc. (MRK) Johnson & Johnson (JNJ) Pfizer, Inc. (PFE) Synthetify (SNY) Bristol-Myers Squibb Co (BMY) Eli Lilly and Company (LLY) AstraZeneca PLC (AZN) GSK plc (GSK) Impossible Finance Launchpad (IDIA) ROGin AI (ROG) AbbVie Inc (ABBV) Incyte Corporation (INCY) Sanofi (SNY) Abivax SA (ABVX) Cytokinetics Inc. (CYTK) NVIDIA Corp. (NVDA) Novo-Nordisk (NVO) TG Therapeutics, Inc. (TGTX) Viking Therapeutics, Inc (VKTX) Microsoft Corp. (MSFT) SpringWorks Therapeutics, Inc. Common Stock (SWTX) Vertex Protocol (VRTX) Gilead Sciences, Inc. (GILD) Intel Corporation (INTC) Advanced Micro Devices (AMD) Oracle Corporation (ORCL) UnitedHealth Group (UNH) Cidara Therapeutics, Inc. (CDTX) Amgen, Inc. (AMGN) Viking Holdings Ltd (VIK) Avidity Biosciences, Inc. (RNA) UBS Group AG (UBS) Biogen Inc (BIIB) Mirati Therapeutics, Inc. Common Stock (MRTX) MGM Resorts International (MGM) DraftKings Inc. Class A Common Stock (DKNG) SPDR S&P [---] ETF Trust (SPY) Amazon.com, Inc. (AMZN) Super Micro Computer, Inc. Common Stock (SMCI)
Top Social Posts
Top posts by engagements in the last [--] hours
"Look like a good opportunity to build a position in Vodafone $VOD today 🤔 $MSFT $SCMN #telecom Vodaphone take over speculation Goldman Sachs a potential buyer $VOD https://t.co/fmSYSgKtYh Vodaphone take over speculation Goldman Sachs a potential buyer $VOD https://t.co/fmSYSgKtYh"
X Link 2024-03-13T14:46Z [----] followers, [----] engagements
"After the deal with Swisscom Whats the next move for Vodafone @bharringtonw11 mentioned a full takeover with a rare alert 🤔 Still a good deal $VOD $MSFT $SCMN $ORA #iliad #telecommunications Look like a good opportunity to build a position in Vodafone $VOD today 🤔 $MSFT $SCMN #telecom Look like a good opportunity to build a position in Vodafone $VOD today 🤔 $MSFT $SCMN #telecom"
X Link 2024-03-19T18:59Z [----] followers, [----] engagements
"Look good for a company with a market cap of 113M : Seres is actively seeking a partner to provide financial resources and other capabilities to support the Companys goal SER-155 clinical trial showed 77% reduction in bloodstream infections Received $175M from VOWS $MCRB $NSRG Seres Therapeutics Reports Third Quarter [----] Financial Results and Provides Business Updates $MCRB https://t.co/KKaRdysYED Seres Therapeutics Reports Third Quarter [----] Financial Results and Provides Business Updates $MCRB https://t.co/KKaRdysYED"
X Link 2024-11-13T12:12Z [----] followers, [----] engagements
"Look good for build a position today in Incyte a lot of rumors the past days $INCY $NVS $SNY $INCY (-11.0% pre) Incyte drops after pausing enrollment in study for urticaria asset - SA https://t.co/QWO1lfwEeT $INCY (-11.0% pre) Incyte drops after pausing enrollment in study for urticaria asset - SA https://t.co/QWO1lfwEeT"
X Link 2024-11-19T14:45Z [----] followers, [---] engagements
"Mkt value 147M today for Seres $MCRB its still undervalued Fact are Nestle have invested a ton of money in this company Do you really still believe that they will not go further Do your own diligence and thank me later 🙃 $NSRGY $MRK $PFE $JNJ We are at 100M mkt So far Nestle has invested around 850M since [----] with the first partnership and the Vowst without the milestones Do you really believe that they will not go further $MCRB $NSRGY $MRK $PFE $JNJ We are at 100M mkt So far Nestle has invested around 850M since [----] with the first partnership and the Vowst without the milestones Do you"
X Link 2024-11-25T17:30Z [----] followers, [----] engagements
"What is cooking with Seres and Nestle Latest update and news on website of Nestle Health its the [--] August [--] Since none update about the Vowst deal and the future $MCRB $NSRG $XBI $IBB Lets go Seres its time to shine 77% relative risk reduction in bacterial bloodstream infections versus placebo Whats the next step Fast track partnership 🤔 $MCRB $NSRGY $NVS $MRK $JNJ Lets go Seres its time to shine 77% relative risk reduction in bacterial bloodstream infections versus placebo Whats the next step Fast track partnership 🤔 $MCRB $NSRGY $NVS $MRK $JNJ"
X Link 2025-01-03T12:55Z [----] followers, [---] engagements
"$MCRB Seres nominate Hans-Juergen Woerle Chief Scientific and Medical Officer Hans-Juergen is responsible for the companys global research and development strategy including translational science clinical development regulatory affairs market access and medical affairs. Very interesting presentation for Seres - https://t.co/EMSmKlL2Lt good opportunity again today😉 $MCRB $NSRGY $JNJ $LLY #Nestle #biotech https://t.co/ZWHFxtsvx1 Very interesting presentation for Seres - https://t.co/EMSmKlL2Lt good opportunity again today😉 $MCRB $NSRGY $JNJ $LLY #Nestle #biotech https://t.co/ZWHFxtsvx1"
X Link 2025-02-11T15:42Z [----] followers, [---] engagements
"The portfolios on which he and his team work span pediatric allergies to oncology to obesity and diabetes to inborn errors of metabolism and more. Thats mean something is cooking behind the scene Partnership or Buyout Make your beats and doo your DD $NSRGY $MRK $SNY"
X Link 2025-02-11T15:42Z [----] followers, [---] engagements
"If we can see similar scenario with Orsted $orsted #energy https://www.doi.dk/en/artikel/norske-opkoebsrygter-sender-oersted-aktien-i-moerkegroent https://www.doi.dk/en/artikel/norske-opkoebsrygter-sender-oersted-aktien-i-moerkegroent"
X Link 2025-03-19T08:36Z [----] followers, [---] engagements
"When the deal will be closed for Gerresheimer CEO On Call Says Takeover Talks Are Ongoing on April [--] [----] $GXI $GXI.DE #warburgpincus #ADIA"
X Link 2025-04-22T20:07Z [----] followers, [---] engagements
"SpringWorks deal with Merck its a good deal $SWTX $MRK.DE Yes No 57$ minimum Yes No 57$ minimum"
X Link 2025-04-28T11:49Z [----] followers, [---] engagements
"$SNY Sanofi buy the blueprint Medicines $BPMC its the second deal for Sanofi this year #biotech $ibb $xbi $SNY $BPMC Press Release: Sanofi to acquire Blueprint Medicines expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology $129.00 per share in cash at closing $9.1 billion + CVR https://t.co/OFYq1uhj53 $SNY $BPMC Press Release: Sanofi to acquire Blueprint Medicines expanding portfolio in rare immunological disease and adding early-stage pipeline in immunology $129.00 per share in cash at closing $9.1 billion + CVR https://t.co/OFYq1uhj53"
X Link 2025-06-02T05:53Z [----] followers, [---] engagements
"Over the last three months the stock of Seres has risen 150%. How much do you think it can do over the next [--] months The FDA return could now come at any time.What are the advanced discussions with the different parties In [--] months it's Christmas🎅🏻 $MCRB $NSRGY $XBI $IBB Mmmm Seres Therapeutics whats is this options calls of October mean 15$ buyer for a value of 800K last week and yesterday buyer of 17.5$ for a value of 600K $MCRB $NSRGY $UNH #biotech #microbiome #optionsalerts Mmmm Seres Therapeutics whats is this options calls of October mean 15$ buyer for a value of 800K last week and"
X Link 2025-08-28T09:07Z [----] followers, [----] engagements
"📊 What the chart shows: Strong rally from $6.20 in early April to $17.40 by early September (+181%). 📊 Key insights from the chart: $MCRB : April 2025: $6.20 Early Sept 2025: $17.40 (+181%) Spiked above $22 intraday after the Sept [--] Nestl $41/share bid"
X Link 2025-09-13T04:16Z [----] followers, [----] engagements
"Good Morning World 🌍 another one ☝🏼 $RHHBY Roche enters into a definitive merger agreement to acquire 89bio $ETNB and its phase [--] FGF21 analog for the therapy of moderate to severe MASH. $14.50 + $6 CVR #biotech $xbi $mcrb $zvra next one https://finance.yahoo.com/news/89bio-inc-announces-agreement-acquired-050200298.html https://finance.yahoo.com/news/89bio-inc-announces-agreement-acquired-050200298.html"
X Link 2025-09-18T06:03Z [----] followers, [---] engagements
"Canaccord raised the price target on Seres Therapeutics to $22 from $14 and keeps a Buy rating on the shares. The firm noted the FDA provided feedback on Seres proposed Phase [--] SER-155 study in bloodstream infections which could aid in partnership discussions $MCRB $XBI $NSRGY Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase [--] Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway $MCRB https://t.co/ejAsK9VSQf Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase [--] Study Protocol and Implements Cost"
X Link 2025-09-24T11:19Z [----] followers, [---] engagements
"Monday buyout $GMAB GENMAB TO ACQUIRE $MRUS MERUS FOR $97 PER SHARE IN AN ALL-CASH TRANSACTION VALUED AT $8 BILLION #biotech $XBI $IBB"
X Link 2025-09-29T08:08Z [----] followers, [---] engagements
"I find this news from NHS very interesting. they havent announced anything since the VOWST. and just three days after the news from Seres they are looking for candidates in the same sector 🤔 Whats thats mean Maybe something maybe nothing $MCRB https://www.nestlehealthscience.com/newsroom/press-releases/applications-for-grants https://www.nestlehealthscience.com/newsroom/press-releases/applications-for-grants"
X Link 2025-10-02T17:49Z [----] followers, [---] engagements
"Very good:H.C. Wainwright Assumed Coverage on $TGTX at Buy-$60 and said: An MS franchise in the making; we expect Briumvi's market penetration to grow significantly in the next few yearsestimate that SC Briumvi could take peak US revenues from $3.1B to $5.1B in [----]. $RHHBY $NVS"
X Link 2025-10-07T16:49Z [----] followers, [---] engagements
"$MCRB Seres cut staff following Nestls request Nestle will cut [-----] jobs and the stock is soaring on the Swiss market by more than 8%. The forecasts are interesting for the NHS because the entity is being maintained and is moving more towards the medical & microbiome $NSRGY"
X Link 2025-10-16T10:36Z [----] followers, [---] engagements
"Dj vu $AVDL $MCRB $AVDL - many will say not much premium today on the buyout - but $AVDL one of those Biotechs that turned profitable and is up nicely from lows $AVDL - many will say not much premium today on the buyout - but $AVDL one of those Biotechs that turned profitable and is up nicely from lows"
X Link 2025-10-22T11:20Z [----] followers, [---] engagements
"Nothing as changed for Seres Therapeutics. Short are covering but stock its not moving in the right way Very strange We are at 22$ on the [--] October Announcement possible at any days now Seat your belt 🚀 $NSRGY $NVS #biotech #merger"
X Link 2025-10-28T16:04Z [----] followers, [--] engagements
"@Kaniel2909 Yes 🙏🏼 a good news today for $MCRB I hope more are coming in the next days - https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-receives-award-36-million-carb-x-develop https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-receives-award-36-million-carb-x-develop"
X Link 2025-10-29T14:14Z [----] followers, [--] engagements
"Wow what a crazy story I have sold all my position this year $AUPH $AUPH Turns out that the LinkedIn post may not have been the height of it if even half of what is alleged in lawsuit is true: https://t.co/CazfhuYZnn $AUPH Turns out that the LinkedIn post may not have been the height of it if even half of what is alleged in lawsuit is true: https://t.co/CazfhuYZnn"
X Link 2025-11-03T09:17Z [----] followers, [---] engagements
"Seres Therapeutics advanced earnings on the [--] November Jurisdiction vs Vedanta are on the [--] November with Nestle hand in hand represented by the same lawyers Whats the next move Buyout or partnership on the [--] November $MCRB $NSRGY $VEDL $XBI #biotech"
X Link 2025-11-04T11:58Z [----] followers, [---] engagements
"Interesting 🧐 A deal between SoftBank & Marvell this two make senses $MRVL $9984.TO SoftBank explored a potential takeover of US chipmaker Marvell Technology earlier this year sources say in what would have been the semiconductor industrys largest-ever deal https://t.co/ecPKpWIjV9 SoftBank explored a potential takeover of US chipmaker Marvell Technology earlier this year sources say in what would have been the semiconductor industrys largest-ever deal https://t.co/ecPKpWIjV9"
X Link 2025-11-06T12:30Z [----] followers, [---] engagements
"Merck $MRK is nearing a deal to buy Cidara Therapeutics $CDTX $XBI $IBB whos next Seres Therapeutics 🙃 $MCRB Merck $MRK is nearing a deal to buy Cidara Therapeutics $CDTX a drugmaker pioneering a long-acting antibody medicine that protects against flu FT reported. @mroliverbarnes @JFK_America A deal valuing Cidara at a premium to its $3.3 billion market capitalisation could be https://t.co/AeXmvK0MYf Merck $MRK is nearing a deal to buy Cidara Therapeutics $CDTX a drugmaker pioneering a long-acting antibody medicine that protects against flu FT reported. @mroliverbarnes @JFK_America A deal"
X Link 2025-11-14T09:11Z [----] followers, [---] engagements
"I like this one $CRSP Crispr Therapeutics will attract a lot of potential buyers Possible target $100 $AMGN $JNJ $ROG.SW #biotech #gene $CRSP +5% CRISPR Therapeutics shares climbed after rumors suggested a large U.S. biopharma company may be exploring a potential acquisition fueled by progress in gene editing programs and growing Casgevy sales. https://t.co/uBxRuFwy04 https://t.co/meZEEDSeRk $CRSP +5% CRISPR Therapeutics shares climbed after rumors suggested a large U.S. biopharma company may be exploring a potential acquisition fueled by progress in gene editing programs and growing Casgevy"
X Link 2025-11-17T22:34Z [----] followers, [---] engagements
"$MCRB The current fair price should be $25-30. Did you remember that : Pursuant to the Purchase Agreement Seres and Nestl Health Science will share 50/50 in the net profit or net loss achieved during the Profit Sharing Period from the date of Closing until December [--] 2025"
X Link 2025-11-17T22:39Z [----] followers, [---] engagements
"LOL just in time with the news results of Viking Therapeutics :) Hey Pfizer whats the offer $PFE $VKTX #biotech #obesity $PFE Pfizer CFO: Company To Look Globally For More Obesity Deals - Will Look To Supplement Metsera Assets $PFE Pfizer CFO: Company To Look Globally For More Obesity Deals - Will Look To Supplement Metsera Assets"
X Link 2025-11-19T09:17Z [----] followers, [---] engagements
"$LLY #1 *ELI LILLY BECOMES FIRST HEALTH-CARE COMPANY WORTH $1 TRILLION $LLY https://t.co/Nb9wonlXeF *ELI LILLY BECOMES FIRST HEALTH-CARE COMPANY WORTH $1 TRILLION $LLY https://t.co/Nb9wonlXeF"
X Link 2025-11-21T15:06Z [----] followers, [---] engagements
"The Art of the negotiations between Novartis & Avidity Bio. $NVS $RNA #biotech M&A $NVS / $RNA Prem14A July 3: $52/share July 9: $60/share July 21: $70/share September 19: $72/share October 26: Deal disclosed Also $RNA disclosed plans to conduct a $500m offering on September [--] https://t.co/xii3qznpby $NVS / $RNA Prem14A July 3: $52/share July 9: $60/share July 21: $70/share September 19: $72/share October 26: Deal disclosed Also $RNA disclosed plans to conduct a $500m offering on September [--] https://t.co/xii3qznpby"
X Link 2025-11-25T02:14Z [----] followers, [---] engagements
"@semodough Its still a buyout candidate 🙃"
X Link 2025-12-02T11:23Z [----] followers, [--] engagements
"Look like a big premium its coming for $ABVX this story remember me $CDTX 😉#biotech $SNY $AZN $ABVX Now they have added Dec19 [---] calls for 400k with one week to expiration https://t.co/81eUOCAPJ9 $ABVX Now they have added Dec19 [---] calls for 400k with one week to expiration https://t.co/81eUOCAPJ9"
X Link 2025-12-09T15:41Z [----] followers, [---] engagements
"Be careful sometimes we win but the losses are always bigger $RZLT $ABVX #Biotech Botech in nutshell $ABVX (LP+C) from [--] to [---] with good data $RZLT (NP) FROM [--] to [---] at bad data Botech in nutshell $ABVX (LP+C) from [--] to [---] with good data $RZLT (NP) FROM [--] to [---] at bad data"
X Link 2025-12-11T14:03Z [----] followers, [---] engagements
"Very good news for the science & the breast cancer I hope this saves more life @AstraZeneca #biotech #breastcancerawareness $AZN $ROG.SW $AZN FDA approval FDA approves fam-trastuzumab deruxtecan-nxki with pertuzumab for unresectable or metastatic HER2-positive breast cancer FDA $AZN FDA approval FDA approves fam-trastuzumab deruxtecan-nxki with pertuzumab for unresectable or metastatic HER2-positive breast cancer FDA"
X Link 2025-12-15T19:06Z [----] followers, [--] engagements
"If down to 95-105$ I will add I dont see a quick buyout before the end of this year But I like the research of @seedy19tron 👌🏼 $ABVX $LLY $SNY $AZN Just correcting some misinformation on this app re $abvx 1) the marketing expense going down is misleading. 1.7m decrease but there was a 1.8m one time cost last year for the same period. So thats actually a 0.1m increase not including that one time cost of rebranding. Just correcting some misinformation on this app re $abvx 1) the marketing expense going down is misleading. 1.7m decrease but there was a 1.8m one time cost last year for the same"
X Link 2025-12-16T09:52Z [----] followers, [----] engagements
"Can we see a hostile takeover for Wave $WVE by GlaxoSmithKline $GSK soon 🤔 $GSK acquires [---] million shares of $WVE at open market $XBI $IBB https://t.co/eqcc8O8iHf $GSK acquires [---] million shares of $WVE at open market $XBI $IBB https://t.co/eqcc8O8iHf"
X Link 2025-12-16T10:25Z [----] followers, [---] engagements
"Boom Now its a candidate for a buyout $CYTK Cytokinetics Announces FDA Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms"
X Link 2025-12-20T08:29Z [----] followers, [----] engagements
"AST space mobile to the moon 🌖 $ASTS BlueBird [--] has left the factory and is headed to space Next stop: Cape Canaveral Florida🚀🚀🚀🚀🚀🚀🚀 Identical to BlueBird [--] BlueBird [--] will also be the largest commercial communications satellite ever launched into low Earth orbit. This marks another milestone as we https://t.co/VWtY8LbibL BlueBird [--] has left the factory and is headed to space Next stop: Cape Canaveral Florida🚀🚀🚀🚀🚀🚀🚀 Identical to BlueBird [--] BlueBird [--] will also be the largest commercial communications satellite ever launched into low Earth orbit. This marks another milestone as"
X Link 2025-12-21T19:35Z [----] followers, [---] engagements
"@RNAiAnalyst The past news concerning Rexel was demented by the company for information"
X Link 2025-12-22T14:14Z [----] followers, [---] engagements
"+9% $CYTK who will be the buyer 🤔 $PFE $MRK $NVS $LLY $ROG Boom Now its a candidate for a buyout $CYTK Cytokinetics Announces FDA Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms Boom Now its a candidate for a buyout $CYTK Cytokinetics Announces FDA Approval of MYQORZO (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms"
X Link 2025-12-22T14:36Z [----] followers, [---] engagements
"@doepke_michel Nothing for Pfizer & Sanofi $PFE & $SNY"
X Link 2025-12-28T22:09Z [----] followers, [---] engagements
"Deal done for $OS at 24$ share. I think the price is low. I would have expected 30$ 🤔 Buyout firm Hg Capital is in advanced talks to acquire OneStream $OS and could announce a deal in the coming days per Bloomberg. https://t.co/2lLqHwYvn3 Buyout firm Hg Capital is in advanced talks to acquire OneStream $OS and could announce a deal in the coming days per Bloomberg. https://t.co/2lLqHwYvn3"
X Link 2026-01-06T17:21Z [----] followers, [---] engagements
"Eli Lilly $LLY we go first with Ventyx $VTYX after closing this deal maybe will come back on the table for $ABVX 🤔 WSJ reports Eli Lilly $LLY is in advanced talks to buy Ventyx Biosciences $VTYX for more than $1B and a deal could be announced soon. Ventyx develops oral drugs for inflammatory diseases including NLRP3-targeting candidates and a mid-stage asset for cardiovascular disease https://t.co/z44NWUeah4 WSJ reports Eli Lilly $LLY is in advanced talks to buy Ventyx Biosciences $VTYX for more than $1B and a deal could be announced soon. Ventyx develops oral drugs for inflammatory diseases"
X Link 2026-01-06T21:44Z [----] followers, [---] engagements
"Lets go 🚀 $XBI $IBB $XBI THERE WILL BE LARGE LATE STAGE TO COMMERCIAL M&A DEALS LIKE ITCI IN [----] - CENTERVIEWS ERIC TOKAT $XBI THERE WILL BE LARGE LATE STAGE TO COMMERCIAL M&A DEALS LIKE ITCI IN [----] - CENTERVIEWS ERIC TOKAT"
X Link 2026-01-07T20:24Z [----] followers, [---] engagements
"Not sure that Sanofi $SNY Will buy $OCUL more better competitors in this segment #biotech $OCUL: Sanofi is preparing an improved takeover bid for Ocular Therapeutix after its initial $16-per-share offer was rejected by the board - per LaLettre https://t.co/gqiSUABntY $OCUL: Sanofi is preparing an improved takeover bid for Ocular Therapeutix after its initial $16-per-share offer was rejected by the board - per LaLettre https://t.co/gqiSUABntY"
X Link 2026-01-15T11:34Z [----] followers, [---] engagements
"I sell my position yesterday at $311 🥲 $PEN $BSX #Healthcare $PEN $BSX Boston Scientific announces agreement to acquire Penumbra Inc. BioPharmCatalyst https://t.co/RdYIn7WbM4 $PEN $BSX Boston Scientific announces agreement to acquire Penumbra Inc. BioPharmCatalyst https://t.co/RdYIn7WbM4"
X Link 2026-01-15T12:20Z [----] followers, [---] engagements
"I like this one long a lot of potential for Archer Aviation $ACHR $ACHR Repeat buying on the 6/16 14c (far OTM) Always tricky playing a breakout especially with demark exhaustion firing here but that signal is not as strong without a big unplug imo so im not to believe this could go First TP would be the volume imbalance above https://t.co/6c1RPhXQlJ $ACHR Repeat buying on the 6/16 14c (far OTM) Always tricky playing a breakout especially with demark exhaustion firing here but that signal is not as strong without a big unplug imo so im not to believe this could go First TP would be the volume"
X Link 2026-01-16T14:56Z [----] followers, [---] engagements
"@Maximus_Holla @monaco_biotech This is like a Betaville number two"
X Link 2026-01-20T09:02Z [----] followers, [---] engagements
"@Maximus_Holla @monaco_biotech Lets see 🙃"
X Link 2026-01-20T09:22Z [----] followers, [--] engagements
"@Maximus_Holla @monaco_biotech "The first step before engaging the govt on this foreign direct investment regulation there must be a step number one: a public transaction communicated between the acquirer and the acquiree. That has not happened." - $ABVX CEO $LLY"
X Link 2026-01-20T14:09Z [----] followers, [---] engagements
"$CAP.pa buy $WNS for 76.50$ 3.3B Capgemini to Buy WNS for $3.3 Billion https://t.co/kUJ5WLCG5G Capgemini to Buy WNS for $3.3 Billion https://t.co/kUJ5WLCG5G"
X Link 2025-07-07T05:57Z [----] followers, [---] engagements
"$MCRB 80% in the last five days and short not covering 🤔 We know the company are backed by Nestle for the Moment. The future of the Microbiome its brillant with a big market value estimates range: $1.3B (2024) growing to $8.9B by 2034; other estimates project $1.27B$2.26B"
X Link 2025-11-20T06:01Z [----] followers, [---] engagements
"I like actually $ASND & $GMAB two Nordic contenders with a big and promising pipeline 🚀 $PFE $NVS $NVO $ABBV Today upgrade for Genmab $GMAB $GMAB.CO of Deutsche Bank for a buy with a new target of [----] DK Still partnership with PfizerAbbvieBioNTech $PFE $ABBV $BNTX $NVS Today upgrade for Genmab $GMAB $GMAB.CO of Deutsche Bank for a buy with a new target of [----] DK Still partnership with PfizerAbbvieBioNTech $PFE $ABBV $BNTX $NVS"
X Link 2025-12-29T22:14Z [----] followers, [---] engagements
"Good entry point today for Ascendis - Upgraded by Wells for overweight 332$ - Disappointed by the news of Abivax $ASND $ABVX #biotech (3/n): $ASND Full-year [----] product revenue of 683m Expect operating cash flow of 500m in [----] Planned$120mshare repurchase program in [----] TransCon CNP PDUFA goal date ofFebruary [--] [----] https://t.co/V2jmjjfzlA (3/n): $ASND Full-year [----] product revenue of 683m Expect operating cash flow of 500m in [----] Planned$120mshare repurchase program in [----] TransCon CNP PDUFA goal date ofFebruary [--] [----] https://t.co/V2jmjjfzlA"
X Link 2026-01-12T14:48Z [----] followers, [----] engagements
"Poseida $PSTX with a mkt cap of 278M acquired by Roche $RHHBY for 1.5B before that stock go to 1.78$ thats company have also a partnership with Roche phase1 a lot of similarities with Seres $MCRB 😉 place your bets https://www.prnewswire.com/news-releases/poseida-therapeutics-inc-announces-agreement-to-be-acquired-by-roche-holdings-inc-302316189.html Roche enters into a definitive agreement to acquire Poseida Therapeutics. $1B plus a CVR. https://www.prnewswire.com/news-releases/poseida-therapeutics-inc-announces-agreement-to-be-acquired-by-roche-holdings-inc-302316189.html Roche enters into"
X Link 2024-11-26T08:12Z [----] followers, [----] engagements
"Novartis still strong $NVS $NOVN.SW Novartis reported a strong quarter with higher-than-expected net sales and core EPS though some drug sales like Cosentyx and Promacta/Revolade fell short of estimates. Novartis reported a strong quarter with higher-than-expected net sales and core EPS though some drug sales like Cosentyx and Promacta/Revolade fell short of estimates"
X Link 2025-07-17T05:10Z [----] followers, [---] engagements
"Make your own DD and you understand Since [----] Nestl Health Science has invested big in Seres Therapeutics: [----] $66.5M + $30M 💵 [----] $175M + $125M 📈 [----] $175M + $18M 🔄 [----] $50M + $25M 💰 Total so far: $664.5M Potential: +$275M milestones #biotech #Nestle $NSRGY $MCRB Over the last three months the stock of Seres has risen 150%. How much do you think it can do over the next [--] months The FDA return could now come at any time.What are the advanced discussions with the different parties In [--] months it's Christmas🎅🏻 $MCRB $NSRGY $XBI $IBB Over the last three months the stock of Seres has"
X Link 2025-09-04T09:15Z [----] followers, [----] engagements
"Nothing as changed for Seres Therapeutics. Short are covering but stock its not moving in the right way Very strange We are at 22$ on the [--] October Announcement possible at any days now Seat your belt 🚀 $MCRB $NSRGY $NVS #biotech #merger 📊 What the chart shows: Strong rally from $6.20 in early April to $17.40 by early September (+181%). 📊 Key insights from the chart: $MCRB : April 2025: $6.20 Early Sept 2025: $17.40 (+181%) Spiked above $22 intraday after the Sept [--] Nestl $41/share bid https://t.co/hmnE8oNuvl 📊 What the chart shows: Strong rally from $6.20 in early April to $17.40 by"
X Link 2025-10-28T18:07Z [----] followers, [---] engagements
"Permira and Warburg Pincus are nearing a deal to acquire investment software maker Clearwater Analytics $CWAN. A deal could be announced as soon as Monday barring any last-minute snags. 24.55$ not bad at all"
X Link 2025-12-21T19:28Z [----] followers, [---] engagements
"GSK $GSK & RAPT $RAPT Wedding 💍👰🏼 day for $58 Congrats 🎊 🙃 #biotech and of course Rapt participated at JPM #Healthcare GSK $GSK to Acquire RAPT Therapeutics $RAPT for $1.9 Billion - 🧬GSK will pay RAPT Therapeutics shareholders $58 per share representing a 65.24% premium from the stocks last close. 🧬A GSK subsidiary will begin a tender offer within [--] business days. 🧬The deal is expected to https://t.co/LwWsxbL9js GSK $GSK to Acquire RAPT Therapeutics $RAPT for $1.9 Billion - 🧬GSK will pay RAPT Therapeutics shareholders $58 per share representing a 65.24% premium from the stocks last"
X Link 2026-01-20T09:01Z [----] followers, [---] engagements
"After the announcement of the partnership with Anthropic UBS upgrade : UBS raises its price target on Genmab to DKK2750 from DKK2700 while maintaining a Buy rating and naming it as top pick for European biotech in [----]. $GMAB $GMAB.co $JNJ $UBS #biotech Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic . https://t.co/l617ChPwXx #AgenticAI Genmab Partners with Anthropic to Accelerate Research and Development Through Agentic . https://t.co/l617ChPwXx #AgenticAI"
X Link 2026-01-08T10:33Z [----] followers, [---] engagements
"Thats the reason Im buying Genmab at discount today $GMAB #biotech $XBI $IBB William Blair reiterated a Buy rating on #Genmab $GMAB citing limited risk to the accelerated approval of Epkinly despite mixed trial results. Truist Financial has similarly maintained a Buy rating with a $48.00 price target Barclays Maintained Buy dkk [-----] William Blair reiterated a Buy rating on #Genmab $GMAB citing limited risk to the accelerated approval of Epkinly despite mixed trial results. Truist Financial has similarly maintained a Buy rating with a $48.00 price target Barclays Maintained Buy dkk 2.500"
X Link 2026-01-19T08:44Z [----] followers, [---] engagements
"$GMAB Handelsbanken believes the market reaction is excessive given that the cancer drug Epkinly developed by the Danish pharmaceutical company Genmab did not clearly improve survival in a Phase [--] trial. This was stated in a commentary published Monday. The company's U.S. registered certificate fell 4.7% on Friday. In today's opening session on the Copenhagen Stock Exchange the share price declined by more than 5% in generally weak markets following Donald Trump's latest statements on tariffs. Handelsbanken emphasizes that Genmab remains one of its preferred Nordic stocks and indicates that"
X Link 2026-01-19T10:02Z [----] followers, [---] engagements
"Genmab will be a big winner this year 💪🏼 Average analyst price is $38 with a high at $48 undervalued a the actual price $GMAB $MRK $JNJ $NVO $XBI $IBB #Biotech With a tipoff from a friend and some info that probably shouldn't have been posted in a trial registry the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK have been revealed. Quite amazing given the recent $GMAB news. Via @ApexOnco - https://t.co/WT8gNUvT83 With a tipoff from a friend and some info that probably shouldn't have been posted in a trial registry the mechanisms of ADCs JNJ-95437446 $JNJ & SKB571/ MK-2750 $MRK"
X Link 2026-02-02T12:59Z [----] followers, [---] engagements
"@bharringtonw11 Betaville spread a new rumor about Seres $MCRB its writes the Nestl would have done an new offer this summer Today Nestle its still one of the big owner of the company Look like something is cooking $NSRGY $NESN.SW $MRK $SNY $NVO #biotech $MCRB +9% amid takeover speculation. However the rumour hasnt been tested through formal journalistic channels. https://t.co/E7pX0mRYY7 $MCRB +9% amid takeover speculation. However the rumour hasnt been tested through formal journalistic channels. https://t.co/E7pX0mRYY7"
X Link 2024-10-10T18:03Z [----] followers, [----] engagements
"Nestl Health Science Turnaround on track double-digit growth Active and medical delivered strong growth 👍🏼 Full takeover of Seres its the next target 🤔 🎯 $MCRB $NSRGY $NESN.sw $MRK $SNY $NVO #biotech"
X Link 2024-10-17T14:11Z [----] followers, [----] engagements
"Seres green on a blood bath 🤔 what will be your vote I come soon with a post about my vote Lets go Nestle make it happen $MCRB $NESN.SW $NSRGY $MRK $JNJ $LLY #biotech You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for Seres. the die is cast in my opinion $MCRB $NSRGY $MRK $JNJ $NVS #Biotech You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for"
X Link 2025-03-26T19:41Z [----] followers, [---] engagements
"Dont miss to vote Last call Management as failed No value for shareholders of Seres I hope Nestle will be on the side of shareholders $MCRB $NSRGY $NESN.SW #biotech #pharma #tariffs To all Seres shareholders I recommend that you vote no to all the proposals. The board and management have brought no added value apart from a terrible fall in the share price. $MCRB $NSRGY #biotech #Nestle https://t.co/sFNoAyHHcz To all Seres shareholders I recommend that you vote no to all the proposals. The board and management have brought no added value apart from a terrible fall in the share price. $MCRB"
X Link 2025-04-07T17:01Z [----] followers, [----] engagements
"$ORSTED.CO 👎🏼 Orsted shares crashed more than 25% on Monday morning after the wind farm developer said it plans a [--] billion Danish kroner ($9.4 billion) rights issue following a material adverse development in the U.S. market. Read Chloe Taylors article for more: https://t.co/wVsWLdwy6v https://t.co/2JVJEV91R9 Orsted shares crashed more than 25% on Monday morning after the wind farm developer said it plans a [--] billion Danish kroner ($9.4 billion) rights issue following a material adverse development in the U.S. market. Read Chloe Taylors article for more: https://t.co/wVsWLdwy6v"
X Link 2025-08-11T08:19Z [----] followers, [--] engagements
"9M-25 highlights: In Nestl Health Science OG for the first nine months was solid with all segments contributing to positive RIG-led growth. In VMS premium brands grew strongly partially offset by the discontinuation of some private label business"
X Link 2025-10-16T10:38Z [----] followers, [---] engagements
"and a weaker performance across some mainstream brands. In Active Nutrition Orgain sustained its strong growth momentum supported by new product launches. In Medical Nutrition solid growth was driven by pediatric care products. #biopharma #biotech $nesn.sw"
X Link 2025-10-16T10:38Z [----] followers, [--] engagements
"Dont worry @MWM76 Today will be a good day for $ALGN :) best management team for the 3rd time https://finance.yahoo.com/news/align-technology-recognized-3rd-time-000200123.html $ALGN silly downgrade right when ALGN is breaking out very sus. Fuck these clowns that play ball that way. I hope a buyout comes and cleans their clock. https://t.co/zghB95SKEt https://finance.yahoo.com/news/align-technology-recognized-3rd-time-000200123.html $ALGN silly downgrade right when ALGN is breaking out very sus. Fuck these clowns that play ball that way. I hope a buyout comes and cleans their clock."
X Link 2025-11-26T06:20Z [----] followers, [---] engagements
"Genmab its a very good company and this results are very good Adding more $GMAB #biotech New standard of care in 2L FL you can drive a truck through those curves Notably the three SUD dosing strategy is new SoC for Epkinly significantly reducing any grade/Gr3 CRS. Congrats to Falce et al. $GMAB #ASH25 https://t.co/bodTu1E6Ib New standard of care in 2L FL you can drive a truck through those curves Notably the three SUD dosing strategy is new SoC for Epkinly significantly reducing any grade/Gr3 CRS. Congrats to Falce et al. $GMAB #ASH25 https://t.co/bodTu1E6Ib"
X Link 2025-12-08T09:44Z [----] followers, [---] engagements
"Still in Genmab Actually my favorite one Sciences always win 😉 $GMAB $PFE Buy now or regret later 🙃 $GMAB $PFE #Biotech Buy now or regret later 🙃 $GMAB $PFE #Biotech"
X Link 2025-12-16T10:27Z [----] followers, [---] engagements
"Today upgrade for Genmab $GMAB $GMAB.CO of Deutsche Bank for a buy with a new target of [----] DK Still partnership with PfizerAbbvieBioNTech $PFE $ABBV $BNTX $NVS Still in Genmab Actually my favorite one Sciences always win 😉 $GMAB $PFE Still in Genmab Actually my favorite one Sciences always win 😉 $GMAB $PFE"
X Link 2025-12-19T07:23Z [----] followers, [---] engagements
"Telecom Italia $TIT.MI Win 1Billion plus 500M in interest Lets see hows the stock react tomorrow 🤔 Telecom Italia to hold Sunday board meeting on savings share conversion plan https://t.co/zlN0BBd6pz https://t.co/zlN0BBd6pz Telecom Italia to hold Sunday board meeting on savings share conversion plan https://t.co/zlN0BBd6pz https://t.co/zlN0BBd6pz"
X Link 2025-12-21T19:31Z [----] followers, [---] engagements
"Nice premium 320% for Vigil Neuroscience $VIGL Sanofi $SNY paid 8$ +$2 CVR when its your turn Seres Therapeutics $MCRB Vigil Gets Scooped Up by Sanofi $SNY $VIGL Another neuro deal another reminder: in biotech clarity and timing still matter. Sanofi is acquiring Vigil Neuroscience for $8/share valuing the company at $470M upfront plus a $2/share CVR if the lead drug hits the market. Thats https://t.co/kUKP9EjGra Vigil Gets Scooped Up by Sanofi $SNY $VIGL Another neuro deal another reminder: in biotech clarity and timing still matter. Sanofi is acquiring Vigil Neuroscience for $8/share valuing"
X Link 2025-05-22T09:09Z [----] followers, [---] engagements
"Loading up on $GMAB before earnings. If they deliver a beat + fresh catalysts this thing wont stay at these levels for long. Added more yesterday. Lets see whos early. $JNJ $ABBV $NVO $PFE $GMAB $ABBV Genmab AbbVie #Epkinly $GMAB $ABBV Genmab AbbVie #Epkinly"
X Link 2026-02-12T05:29Z [----] followers, [----] engagements
"Now @Idorsia target is 30CHF by @DeutscheBank with very good analysis. Potential revenue of 4Billions with her actually Pipeline #idorsia #biotech #medical #drugs #pharma $IDIA"
X Link 2018-05-31T09:41Z [----] followers, [--] engagements
"Nice 👍🏼 $IDIA Thank you @Lundquist for the shout out Happy to see the results but the work is not done as we definitely have more improvements planned for [----]. Check out our website at https://t.co/ZsWVf08NDZ Thank you @Lundquist for the shout out Happy to see the results but the work is not done as we definitely have more improvements planned for [----]. Check out our website at https://t.co/ZsWVf08NDZ"
X Link 2019-01-08T11:27Z [----] followers, [--] engagements
"$IDIA Idorsia says stay tuned 🚀🚀🚀 UPDATE 2-Swiss Idorsia says 'stay tuned' for deals as it manages pipeline - Reuters UPDATE 2-Swiss Idorsia says 'stay tuned' for deals as it manages pipeline - Reuters"
X Link 2019-02-08T08:28Z [----] followers, [--] engagements
""With Idorsia we do not want to repeat the Actelion story we want to much better" says J-P Clozel $IDIA Serial entrepreneurs par excellence - Martine and Jean-Paul Clozel on stage at #SEF19 : "With Idorsia we do not want to repeat the Actelion story we want to much better" https://t.co/Dl2M8WGPSq Serial entrepreneurs par excellence - Martine and Jean-Paul Clozel on stage at #SEF19 : "With Idorsia we do not want to repeat the Actelion story we want to much better" https://t.co/Dl2M8WGPSq"
X Link 2019-05-24T09:17Z [----] followers, [--] engagements
"$IDIA Clinical data for our investigational therapy for the treatment of adult and elderly patients with insomnia have been presented at #SLEEP2019 in San Antonio (Texas USA). Read more in our press release https://t.co/nUhPtm1Oak Clinical data for our investigational therapy for the treatment of adult and elderly patients with insomnia have been presented at #SLEEP2019 in San Antonio (Texas USA). Read more in our press release https://t.co/nUhPtm1Oak"
X Link 2019-06-13T05:28Z [----] followers, [--] engagements
"🧪 👨🍳 $IDIA Idorsia will be profitable in [----] Idorsia vise la rentabilit l'horizon [----] (CEO) https://t.co/W6cOa8kM92 #Idorsia Idorsia vise la rentabilit l'horizon [----] (CEO) https://t.co/W6cOa8kM92 #Idorsia"
X Link 2019-08-26T09:36Z [----] followers, [--] engagements
"👍🏼 * AGNAFIT BIDCO IS OFFERING SEK [---] PER SOBI SHARE WHICH VALUES ISSUED SHARE CAPITAL OF SOBI AT APPROXIMATELY SEK [----] BILLION * BOARD OF DIRECTORS OF SWEDISH ORPHAN BIOVITRUM AB UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS OF SWEDISH ORPHAN BIOVITRUM $SOBI Now its look like is too late for the train 🚂 $SOBI 👍🏼 Now its look like is too late for the train 🚂 $SOBI 👍🏼"
X Link 2021-09-02T06:06Z [----] followers, [--] engagements
"A lot of deal this month After yesterday Pfizer and Arena today CSL and Vifor whos next 🤔 $PFE $ARNA $CSL $VIFN $BMY $AUPH #biotech #BigPharma Australia's CSL makes $11.7 billion cash offer for Switzerland's Vifor Pharma https://t.co/DdyxwMYPBb Australia's CSL makes $11.7 billion cash offer for Switzerland's Vifor Pharma https://t.co/DdyxwMYPBb"
X Link 2021-12-14T06:54Z [----] followers, [--] engagements
"Sounds good 👍🏼 #idorsia $IDIA $IDRSF - Idorsia: The Foundation Is In Place And The Co. Is Ready For Great Success In [----]. https://t.co/6ZLvZOPsnH #stocks #trading #investing $IDRSF - Idorsia: The Foundation Is In Place And The Co. Is Ready For Great Success In [----]. https://t.co/6ZLvZOPsnH #stocks #trading #investing"
X Link 2023-01-03T09:59Z [----] followers, [---] engagements
"Very good news for Aurinia whats the next move #biotech $AUPH $OTSK $BMY $GSK $AUPH - Aurinia shares jump 36% on patent challenge settlement with India's Sun Pharma https://t.co/8lAnLUdUZD $AUPH - Aurinia shares jump 36% on patent challenge settlement with India's Sun Pharma https://t.co/8lAnLUdUZD"
X Link 2023-01-03T14:48Z [----] followers, [---] engagements
"Big Pharma want the big deal 😉 Who will be the Winner $AUPH $TGTX $AXSM $AMLX #biotech $NVS $PFE $MRK 🤔🎯 my actual favorite is @AuriniaPharma or maybe @TGTherapeutics 🙏🏼 https://www.wsj.com/articles/pfizer-novartis-merck-executives-say-they-are-hunting-for-deals-again-11675907783 https://www.wsj.com/articles/pfizer-novartis-merck-executives-say-they-are-hunting-for-deals-again-11675907783"
X Link 2023-02-09T14:00Z [----] followers, [----] engagements
"Mmm who Will be the buyer for $APLS 🤔 #biotech #bigpharma $BMY $NVS $MRK $JNJ"
X Link 2023-04-02T20:39Z [----] followers, [---] engagements
"Mmmm $AUPH Scripts growth so fast 🤔 do you see last candle 🚀 last call Who will be the Winner 🎰 $BMY $AZN $NVS $BIIB $JNJ $XBI $IBB #BigPharma #biotech"
X Link 2023-04-07T14:18Z [----] followers, [----] engagements
"@TomSilver39 Totally absurd because all the analysts projected sales at 1-2B in 2019-2020 TP-30 to [--] and today we have not even reached 1/4 in the salesthe company must be sold as soon as possible to execute its potential $AUPH $XBI $NVS $BMY #biotech"
X Link 2023-06-25T11:31Z [----] followers, [---] engagements
"Its time to to take the train at the right time for Seres. Named to Time [---] most influential companies 💪🏼 who will be the Winners Look like Nestle no or maybe $JNJ 🤔 $NESN $MCRB #biotech #time100"
X Link 2023-06-21T16:30Z [----] followers, [---] engagements
"@TomSilver39 Look like $ABBV will be the dark horse for $AUPH 🤔"
X Link 2023-08-16T19:47Z [----] followers, [---] engagements
"@unemon1 What about $BMY I dont see $NVS for $AUPH 🤔 and why $VRTX"
X Link 2023-09-06T17:03Z [----] followers, [---] engagements
"Recovery mode ON for $AUPH look like its the last call Whats your target price for a buyout $BMY $NVS $ROG $VRTX $GSK $AZN #biotech"
X Link 2023-09-07T14:27Z [----] followers, [---] engagements
"Roche is looking for big acquisitions Would Aurinia be a good candidate $AUPH $ROG $NVS $BMY $GSK $AZH $JNJ $VRTX #biotech #buyout"
X Link 2023-09-11T09:49Z [----] followers, [---] engagements
"@unemon1 @AuriniaPharma Look like something is cooking 🧑🍳 🤔 $AUPH $ABBV $BMY $AZN"
X Link 2023-09-20T17:39Z [----] followers, [---] engagements
"Hey @unemon1 whats your opinion about that - $AUPH $BMY $ABBV $JNJ $PFE $AZN $HEPA #biotech #buyout M&A"
X Link 2023-09-21T12:09Z [----] followers, [---] engagements
"Big volume for Mirati without any news 🤔 no news about the new management 🧑🍳 Fastening your seat belts is just the beginning 🚀 $MRTX $AZB $BMY $BAYER $LLY $PFE $ROG Looks like something is cooking 🤔 $MRTX #biotech Looks like something is cooking 🤔 $MRTX #biotech"
X Link 2023-09-21T18:36Z [----] followers, [----] engagements
"Very good opportunity to buy a position in Kindred group - The next earnings with an update on strategic review are on 29th Nov make your bet 🎰 $kind $mgm $ent $fltr #tech #gambling $Kind - Opened a long position (25 %) in Kindred Group as the stock trade pretty cheap - Will add more shares at SEK [--] https://t.co/WxKPLz6AHJ $Kind - Opened a long position (25 %) in Kindred Group as the stock trade pretty cheap - Will add more shares at SEK [--] https://t.co/WxKPLz6AHJ"
X Link 2023-10-16T11:32Z [----] followers, [---] engagements
"$CYTK - Cytokinetics surges amid report of takeover interest - Bloomberg Swiss company are mentioned for a potential bidder 🤔 $NVS or $ROG maybe $SNY #novartis #roche #sanofi"
X Link 2023-10-31T17:36Z [----] followers, [---] engagements
"@adamfeuerstein $SRPT will recover fast thats a very good opportunity to buy -🚀"
X Link 2023-10-31T17:40Z [----] followers, [---] engagements
"Another beat for the earnings 💪🏼 now its time to listen the conf call about the SR - $AUPH Q3 net product revenue $40.8M. 60% YoY. Achieved European pricing and reimbursement milestone triggering $10M payment from Otsuka. FY'23 net product revenue guidance range to $160"
X Link 2023-11-02T10:12Z [----] followers, [---] engagements
"Next one is Kindred group no A lot of similarity with GAN @puppyeh1 $KIND $GAN $MGM $ENT $FLTR $DKNG #iGames #tech $GAN taken out at $1.97 by Sega Sammy about a 80% premium versus when this thread went out. Thanks for playing 🙏🏻 https://t.co/O91G64c7NO $GAN taken out at $1.97 by Sega Sammy about a 80% premium versus when this thread went out. Thanks for playing 🙏🏻 https://t.co/O91G64c7NO"
X Link 2023-11-08T08:47Z [----] followers, [----] engagements
"A lot of interest for M&A in the gambling sector $KIND (Kindred group) its my favorite for the moment $888 $DKNG $FLTR $ENT $EVO [---] rejected a 700m takeover from Playtech in July $KIND $BETS $KAMBI https://t.co/7ZihM4b4qP [---] rejected a 700m takeover from Playtech in July $KIND $BETS $KAMBI https://t.co/7ZihM4b4qP"
X Link 2023-12-05T07:37Z [----] followers, [---] engagements
"True story and nice Analysis of Aurinia by @unemon1 $Auph between hands of the BP sales will be now around 0.8-1B place your bets now 🎰 its the last call before the train leaves the station $GSK $GILD $JNJ $SNY $NVS #biotech $AUPH . hard to see how LUPKYNIS in the hands of GSK won't be a 1b+ DRUG a year Used safes Assumptions: [--]. 35% of SLE Patients develop LN (GSK states 40% on it's website) [--]. LUPKYNIS costs double Benlysta (in reality it's more) Not surprised if this is JPM model used https://t.co/J4PZjw3YWl $AUPH . hard to see how LUPKYNIS in the hands of GSK won't be a 1b+ DRUG a year"
X Link 2023-12-06T18:38Z [----] followers, [----] engagements
"Its next $AUPH $BMY make two buyout in one month $KRTX & today $RYZB - $ABBV also two buyout $IMGN & $CERE lets go $GSK & $JNJ make it happen :) #biotech"
X Link 2023-12-26T13:27Z [----] followers, [---] engagements
"Mmm Cytokinetics $CYTK remind me the same tragic story with Aurinia $AUPH 🤔 #biotech $NVS $BMY $JNJ #buyout"
X Link 2024-01-09T17:36Z [----] followers, [----] engagements
"Same story repetition with Cytokinetics 🤔 $CYTK $MRTX #biotech $MRK Looks like something is cooking 🤔 $MRTX #biotech Looks like something is cooking 🤔 $MRTX #biotech"
X Link 2024-02-04T17:25Z [----] followers, [----] engagements
"Drug maker Novartis is in advanced talks to acquire MorphoSys a developer of cancer treatments that has a market value of [---] billion euros two people familiar with the matter said on Monday Novartis has so far prevailed over rival drug maker Incyte $mor $nvs $mor.de $incy"
X Link 2024-02-05T16:30Z [----] followers, [---] engagements
"@apefathers16060 The main ticker is in Germany $MOR.DE and its close at [-----] today the ticker in US its an ADR If we see [--] in Germany the stock in us will be around 22-23$ $MOR $NVS $INCY"
X Link 2024-02-05T17:35Z [----] followers, [---] engagements
"Deal done Novartis buy MorphoSys for [--] per share $NVS $NOVN $MOR $MOR.DE Cam novartis buy incyte in the future 🤔 $INCY Drug maker Novartis is in advanced talks to acquire MorphoSys a developer of cancer treatments that has a market value of [---] billion euros two people familiar with the matter said on Monday Novartis has so far prevailed over rival drug maker Incyte $mor $nvs $mor.de $incy Drug maker Novartis is in advanced talks to acquire MorphoSys a developer of cancer treatments that has a market value of [---] billion euros two people familiar with the matter said on Monday Novartis has"
X Link 2024-02-05T22:21Z [----] followers, [---] engagements
"MorphoSys Spokesperson Says "This Story Is Factually Wrong" In An Emailed Statement To Bloomberg News In Response To STAT News' Adam Feuerstein Article Entitled "Why Novartis Is Going To Walk Away From Its Acquisition" Whats happen @adamfeuerstein Fake News $NVS $MOR $INCY"
X Link 2024-02-06T19:36Z [----] followers, [---] engagements
"Last run or end of run for Aurinia Tonight the earnings of Gilead after hours Rumored for potential buyer $GILD Earnings of $AUPH are scheduled for the [--] Feb. with company update on the same day earnings of Otsuka Place your bets no more bets 🎰 $XBI $NVS $AZN $SNY"
X Link 2024-02-06T20:05Z [----] followers, [---] engagements
"Shopping Time 🙃 What you buy today $XBI $SPY $BCYC & $SWTX or $CYTK maybe $AUPH Or the big player $AMZN $TSLA $NVDA"
X Link 2024-02-13T14:37Z [----] followers, [---] engagements
"Very disappointed by @AuriniaPharma $AUPH I lose a ton of money Icant believe the SR end with no formal Bid Whats the problem with the company We need to know the truth How much are the bid Need a EGM @TonKhalife @unemon1 $XBI $BMY $NVS $GILD $OTSKY"
X Link 2024-02-15T15:35Z [----] followers, [----] engagements
"Viking $VKTX its probably the next big candidate for a buyout we will se $80 before end of year - $JNJ $PFE $SNY Leerink:' $VKTX VENTURE Data Shows 13% Pbo-Adj Weight Loss for SC '2735; Clear Win for VKTX." https://t.co/GiG8pW7nU7 Leerink:' $VKTX VENTURE Data Shows 13% Pbo-Adj Weight Loss for SC '2735; Clear Win for VKTX." https://t.co/GiG8pW7nU7"
X Link 2024-02-27T15:31Z [----] followers, [---] engagements
"Finally Idorsia is back on the game 💪🏼 $IDIA $VTRS $JNJ #biotech We are very proud to announce today that the US FDA has approved our drug for the treatment of high blood pressure in combination with other antihypertensives. Read more: https://t.co/1Wdae9od63 https://t.co/l4hBBRpk29 We are very proud to announce today that the US FDA has approved our drug for the treatment of high blood pressure in combination with other antihypertensives. Read more: https://t.co/1Wdae9od63 https://t.co/l4hBBRpk29"
X Link 2024-03-20T06:33Z [----] followers, [---] engagements
"I probably have find the next Super Micro $SMCI - Keep an eye on $SMTC Baird adds Se tech to the fresh picks list Baird said the semiconductor manufacturer is a hidden AI gem. $NVDA $AMD $INTC $DELL #semiconductors"
X Link 2024-03-27T18:19Z [----] followers, [---] engagements
"Not bad for Semtech $SMTC - Net sales of $192.9 million above the midpoint of guidance [--] GAAP gross margin of (0.2)% and Non-GAAP gross margin of 48.9% above the midpoint of guidance - Positive operating cash flow of $13.9 million and free cash flow of $12.2 million $SMCI $SPY I probably have find the next Super Micro $SMCI - Keep an eye on $SMTC Baird adds Se tech to the fresh picks list Baird said the semiconductor manufacturer is a hidden AI gem. $NVDA $AMD $INTC $DELL #semiconductors I probably have find the next Super Micro $SMCI - Keep an eye on $SMTC Baird adds Se tech to the fresh"
X Link 2024-03-28T20:36Z [----] followers, [---] engagements
"Skynet on the way 🤔 Microsoft $MSFT opens new tab and OpenAI are working on plans for a data center project that could cost as much as $100 billion and include an artificial intelligence supercomputer called "Stargate" set to launch in [----] $NVDA #OpenAI https://www.reuters.com/technology/microsoft-openai-planning-100-billion-data-center-project-information-reports-2024-03-29/ https://www.reuters.com/technology/microsoft-openai-planning-100-billion-data-center-project-information-reports-2024-03-29/"
X Link 2024-04-02T03:04Z [----] followers, [---] engagements
"Look Peter takes notes before the end $AUPH $VRTX acquire $ALPN whos traded a 6$ at the 52week lows $XBI Vertex $VRTX enters into an agreement to ACQUIRE Alpine Immune Sciences $ALPN for $65 per share or about $4.9 billion in cash. Vertex $VRTX enters into an agreement to ACQUIRE Alpine Immune Sciences $ALPN for $65 per share or about $4.9 billion in cash"
X Link 2024-04-10T20:15Z [----] followers, [----] engagements
"Comme of $JPM for $DAWN - With a clean label and early approval of Ojemda in r/r pLGG we see DAWN shares moving into the high-teens to low-$20s / share level" reit their OW and $36 PT #biotech $DAWN PR. OJEMDA Receives FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) the Most Common Form of Childhood Brain Tumor. https://t.co/uOkAGgRYhV $DAWN PR. OJEMDA Receives FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG) the Most Common Form of Childhood Brain Tumor. https://t.co/uOkAGgRYhV"
X Link 2024-04-23T20:03Z [----] followers, [---] engagements
"Back in Seres $MCRB earnings are in two days I see a lot of strength in the vol the past month Seres is eligible to receive of Nestl payments of up to $225 million for the achievement of specified net sales milestones $XBI $NSRGY $NESN Now look good for Seres $MCRB 🤔 Nestle confirm the sells of peanut allergy business to stallergenes $NSRGY $NESN #biotech https://t.co/VeEftkRVk2 Now look good for Seres $MCRB 🤔 Nestle confirm the sells of peanut allergy business to stallergenes $NSRGY $NESN #biotech https://t.co/VeEftkRVk2"
X Link 2024-05-06T17:52Z [----] followers, [----] engagements
"Vote are done with a withhold for all Aurinia 👍🏼 you have [--] days left Peter Enjoy $AUPH $XBI $PFE $NVS $BMY $SNY"
X Link 2024-05-15T08:07Z [----] followers, [----] engagements
"Whats the conditions of the deal with Nestl for Seres Memorandum not an final agreement no PR of Nestle 🤔 Looks a good entry today $MCRB $NSRGY $NESN #biotech https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-enters-memorandum-understanding-vowsttm-asset Very good analysis 👍🏼 $MCRB @Jad121212 https://ir.serestherapeutics.com/news-releases/news-release-details/seres-therapeutics-enters-memorandum-understanding-vowsttm-asset Very good analysis 👍🏼 $MCRB @Jad121212"
X Link 2024-06-06T13:46Z [----] followers, [----] engagements
"I see a good opportunity at this level for Seres 😉 $MCRB $NESN $NSRGY $LLY #biotech Whats the conditions of the deal with Nestl for Seres Memorandum not an final agreement no PR of Nestle 🤔 Looks a good entry today $MCRB $NSRGY $NESN #biotech https://t.co/QbvVSFwu7i Whats the conditions of the deal with Nestl for Seres Memorandum not an final agreement no PR of Nestle 🤔 Looks a good entry today $MCRB $NSRGY $NESN #biotech https://t.co/QbvVSFwu7i"
X Link 2024-06-07T19:01Z [----] followers, [---] engagements
"Congrats to all the shareholders 👏🏼 We won AGM the best is yet to come 🚀 Bye Peter $AUPH $XBI $PFE $BMY $NVS $SNY https://www.auriniapharma.com/investors-and-media/news-events/press-releases/detail/330/aurinia-announces-2024-annual-general-meeting-results Vote are done with a withhold for all Aurinia 👍🏼 you have [--] days left Peter Enjoy $AUPH $XBI $PFE $NVS $BMY $SNY https://t.co/UG5uQUdJCB https://www.auriniapharma.com/investors-and-media/news-events/press-releases/detail/330/aurinia-announces-2024-annual-general-meeting-results Vote are done with a withhold for all Aurinia 👍🏼 you"
X Link 2024-06-14T17:19Z [----] followers, [---] engagements
"The move of today are very strangefor hubspot $HUBS $GOOG Google its not the only one interested (betavile article) maybe $MSFT or something others still in #bigtech #tech #cloud #cmr $HUBS Google Reportedly Shelving Bid; Creates Buying Opportunity - RBC PT $700 $HUBS Google Reportedly Shelving Bid; Creates Buying Opportunity - RBC PT $700"
X Link 2024-07-10T20:27Z [----] followers, [---] engagements
"Look like something is cooking with Seres $MCRB $NSRGY $NESN $MRK $SNY #biotech $MCRB This MOU was PRd to global markets to let large pharma know theyre for sale I have no doubt of it now. Float will be all banks and funds by September its being swallowed up $MCRB This MOU was PRd to global markets to let large pharma know theyre for sale I have no doubt of it now. Float will be all banks and funds by September its being swallowed up"
X Link 2024-07-10T20:29Z [----] followers, [----] engagements
"What an opportunity at this price for Seres if the results of Ser-155 are good we can see easy a 100-150% run Any update about rumors of Nestl $MCRB $NSRGY $NESN $MRK $SNY Look like something is cooking with Seres $MCRB $NSRGY $NESN $MRK $SNY #biotech Look like something is cooking with Seres $MCRB $NSRGY $NESN $MRK $SNY #biotech"
X Link 2024-09-10T17:47Z [----] followers, [----] engagements
"@solferglc @said_boussalem This is a projection of analyses unfortunately I did not understand the downward movement after excellent results $MCRB"
X Link 2024-09-13T05:20Z [----] followers, [---] engagements
"@bio_clouseau @monaco_biotech Aurinia are more better VOC works in [--] months hence [--] weeks to provide sustained complete renal response in twice as many patients as placebo versus Roches drug at [--] weeks clearly VOC is far superior $AUPH"
X Link 2024-09-26T10:07Z [----] followers, [---] engagements
"That would be a good candidate for Shopify $SHOP $LSPD Exclusive: Canadian payments software firm Lightspeed explores sale sources say @MilanaVinn $LSPD https://t.co/QtV6CNEEuW Exclusive: Canadian payments software firm Lightspeed explores sale sources say @MilanaVinn $LSPD https://t.co/QtV6CNEEuW"
X Link 2024-09-26T10:31Z [----] followers, [---] engagements
"Why the price its in this level🤔 Company is undervalued soon the deal is closed and Ser-155 go to fast track FDA Nestle backup the company till 2025💪🏼 and and it becomes soon the big investor with a board seat Its time to play big Im adding today $MCRB $NSRGY $MRK $SNY $NOVO What an opportunity at this price for Seres if the results of Ser-155 are good we can see easy a 100-150% run Any update about rumors of Nestl $MCRB $NSRGY $NESN $MRK $SNY What an opportunity at this price for Seres if the results of Ser-155 are good we can see easy a 100-150% run Any update about rumors of Nestl $MCRB"
X Link 2024-09-26T16:47Z [----] followers, [----] engagements
"Welcome back Seres 🚀 What a come back from the hellWhy nestle didn't do PR for the closing of the vowst I hope good news coming soon 🙏🏼 $MCRB $NSRGY $NESN $MRK $SNY $NOVO #biotech Why the price its in this level🤔 Company is undervalued soon the deal is closed and Ser-155 go to fast track FDA Nestle backup the company till 2025💪🏼 and and it becomes soon the big investor with a board seat Its time to play big Im adding today $MCRB $NSRGY $MRK $SNY $NOVO Why the price its in this level🤔 Company is undervalued soon the deal is closed and Ser-155 go to fast track FDA Nestle backup the"
X Link 2024-10-01T20:07Z [----] followers, [----] engagements
"Thats a little bit story about Nestle and Aimmune a lot of similarities with Seres $MCRB : NHSc currently has a total investment in Aimmune of USD473 million an approximate 25.6% equity ownership stake. Around 19.6% is voting common stock and the balance non-voting preferred"
X Link 2024-10-25T12:12Z [----] followers, [---] engagements
"stock. NHSc made its initial investment of USD145 million in Aimmune in November [----] followed by further investments of USD30 million in February [----] USD98 million in November [----] and USD200 million in January [----]. Nestl S.A.s acquired Aimmune for 34.50$ $NSRGY #biotech"
X Link 2024-10-25T12:12Z [----] followers, [---] engagements
"Next stock market crash is coming this year or in [----] #market #finance $BAC $JPM $UBS $MS $WFC $C #bank"
X Link 2024-10-30T20:26Z [----] followers, [---] engagements
"Still no date for the earnings of Seres $MCRB why this silence Pending news We need a CEO like Viking with a transparent communication $VKTX #biotech no communication about the deal Vowst by Nestle $NSRGY Hey @SeresTX when its the earnings $MCRB Hey @SeresTX when its the earnings $MCRB"
X Link 2024-11-05T17:47Z [----] followers, [----] engagements
"We have engaged MTS Health Partners to facilitate the processProcess of what 🤔 The JPM analyst asked about this and Eric's response was that it could happen very quickly and then that there was no need for partnership.it's a lying poker game $MCRB $NSRGY $MRK $SNY $PFE #bio Look good for a company with a market cap of 113M : Seres is actively seeking a partner to provide financial resources and other capabilities to support the Companys goal SER-155 clinical trial showed 77% reduction in bloodstream infections Received $175M from VOWS $MCRB $NSRG Look good for a company with a market cap of"
X Link 2024-11-13T19:39Z [----] followers, [---] engagements
"$ALKS $DVA $JBL $RL - Alkermes DaVita Jabil Ralph Lauren among potential M&A candidates - BofA $BAC"
X Link 2024-11-18T17:46Z [----] followers, [---] engagements
"We are at 100M mkt So far Nestle has invested around 850M since [----] with the first partnership and the Vowst without the milestones Do you really believe that they will not go further $MCRB $NSRGY $MRK $PFE $JNJ Look good for a company with a market cap of 113M : Seres is actively seeking a partner to provide financial resources and other capabilities to support the Companys goal SER-155 clinical trial showed 77% reduction in bloodstream infections Received $175M from VOWS $MCRB $NSRG Look good for a company with a market cap of 113M : Seres is actively seeking a partner to provide financial"
X Link 2024-11-18T17:48Z [----] followers, [----] engagements
"BridgeBio Its a life savior and a big target for Big Pharma $BBIO $PFE $JNJ $NVS $ROG $MRK $BBIO "To honor the courage of our U.S. clinical trial participants BridgeBio will provide these patients Attruby free for life" nice to see $BBIO "To honor the courage of our U.S. clinical trial participants BridgeBio will provide these patients Attruby free for life" nice to see"
X Link 2024-11-23T08:48Z [----] followers, [----] engagements
"Lets go Seres its time to shine 77% relative risk reduction in bacterial bloodstream infections versus placebo Whats the next step Fast track partnership 🤔 $MCRB $NSRGY $NVS $MRK $JNJ FDA Grants Breakthrough Therapy Designation to Seres Therapeutics SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) $MCRB https://t.co/JCUuQli4MN FDA Grants Breakthrough Therapy Designation to Seres Therapeutics SER-155 for Reduction of Bloodstream Infections in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant"
X Link 2024-12-09T12:17Z [----] followers, [----] engagements
"Very interesting presentation for Seres - good opportunity again today😉 $MCRB $NSRGY $JNJ $LLY #Nestle #biotech https://ir.serestherapeutics.com/node/12291/html Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates $MCRB https://t.co/4mwMUTlL5C https://ir.serestherapeutics.com/node/12291/html Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates $MCRB https://t.co/4mwMUTlL5C"
X Link 2025-01-13T15:37Z [----] followers, [----] engagements
"@faststocknewss SpringWorks Therapeutics: FDA approves mirdametinib for adult and pediatric patients with neurofibromatosis type [--] who have symptomatic plexiform neurofibromas not amenable to complete resection $SWTX $MRK"
X Link 2025-02-11T20:49Z [----] followers, [---] engagements
"Step by step Seres Everything looks good for a success story with the FDA Who will be the partner or the buyer 🤔 $MCRB $MRK $JNJ $GSK $PFE $NSRGY #nestle Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach $MCRB https://t.co/HZnXq9MPK3 Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach $MCRB https://t.co/HZnXq9MPK3"
X Link 2025-03-03T13:05Z [----] followers, [---] engagements
"Traded last year at 0.88$ $CMRX $JAZZ $MCRB $JAZZ to Acquire $CMRX for $8.55 per share $JAZZ to Acquire $CMRX for $8.55 per share"
X Link 2025-03-05T13:15Z [----] followers, [---] engagements
"You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for Seres. the die is cast in my opinion $MCRB $NSRGY $MRK $JNJ $NVS #Biotech $MCRB Seres Therapeutics reports FY24 EPS (81c) consensus (20c) "We have made significant progress advancing SER-155 as a novel live biotherapeutic candidate designed to prevent life-threatening bloodstream infections in allo-HSCT recipients" said Eric Shaff President and $MCRB Seres Therapeutics reports FY24 EPS (81c) consensus (20c) "We have"
X Link 2025-03-13T15:27Z [----] followers, [----] engagements
"Did you buy Incyte at this level $incy $nvs $mrk #biotech $xbi $ibb"
X Link 2025-03-14T13:08Z [----] followers, [---] engagements
"I regret not having buy some yesterday let's go Seres & come on Nestl $MCRB $TGTX $NSRGY $NVS $MRK $JNJ #biotech $xbi $ibb You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for Seres. the die is cast in my opinion $MCRB $NSRGY $MRK $JNJ $NVS #Biotech You still can't read between the lines They appointed a member of Nestl to the Board the CMO resigned and you continue to believe that nothing is happening behind the scenes for Seres. the die is cast in my opinion $MCRB"
X Link 2025-03-14T17:06Z [----] followers, [---] engagements
"All Pharma & Biotech sector waiting on this tariffs to make the deal happen💰🍀 $xbi $ibb $jnj $mrk $lly $nvs $azn #biotech #pharma JUST IN: President Trump is set to announce new pharmaceutical tariffs JUST IN: President Trump is set to announce new pharmaceutical tariffs"
X Link 2025-03-28T20:49Z [----] followers, [---] engagements
"To all Seres shareholders I recommend that you vote no to all the proposals. The board and management have brought no added value apart from a terrible fall in the share price. $MCRB $NSRGY #biotech #Nestle"
X Link 2025-04-02T19:32Z [----] followers, [----] engagements
"The future looks bright and I'm sure that with the appointment of Dr. Woerle the company is at a turning point. Together we can make a difference. All the best"
X Link 2025-04-02T19:32Z [----] followers, [---] engagements
"Tariffs of the Pharmaceutical products will not be subject to reciprocal tariffs for now Seres Therapeutics not concerned $MCRB #tariffs #biotech $NESN.SW"
X Link 2025-04-03T04:43Z [----] followers, [---] engagements
"Whats the news Seres Why any PR after the vote and the filling of RS yesterday Its the last run or a deal done Who will be the partner Nestle again Merk 🤔 $MCRB $NSRGY $MRK #biotech Dont miss to vote Last call Management as failed No value for shareholders of Seres I hope Nestle will be on the side of shareholders $MCRB $NSRGY $NESN.SW #biotech #pharma #tariffs Dont miss to vote Last call Management as failed No value for shareholders of Seres I hope Nestle will be on the side of shareholders $MCRB $NSRGY $NESN.SW #biotech #pharma #tariffs"
X Link 2025-04-15T18:58Z [----] followers, [----] engagements
"Before the buyout of Sigilon $SGTX a company owned by Flagship the same company behind Seres $MCRB There was a corporate split and the company was bought out a month later. Nestle's earnings are out this Thursday I hope we see big news coming $NSRGY $NESN.SW $LLY Whats the news Seres Why any PR after the vote and the filling of RS yesterday Its the last run or a deal done Who will be the partner Nestle again Merk 🤔 $MCRB $NSRGY $MRK #biotech Whats the news Seres Why any PR after the vote and the filling of RS yesterday Its the last run or a deal done Who will be the partner Nestle again Merk"
X Link 2025-04-22T19:10Z [----] followers, [---] engagements
"@PK_Fund I see more Roche $ROG to acquire TG Therapeutics $TGTX but Sanofi its a good scenario $SNY"
X Link 2025-04-24T13:19Z [----] followers, [---] engagements
"Good deal 7+7 👍🏼 $RGLS $NVS Soon Seres $MCRB $RGLS (halted pre) Regulus Therapeutics (RGLS) to be Acquired by Novartis $NVS for $7 Per Share - SI https://t.co/nPzHAsBXzH $RGLS (halted pre) Regulus Therapeutics (RGLS) to be Acquired by Novartis $NVS for $7 Per Share - SI https://t.co/nPzHAsBXzH"
X Link 2025-04-30T11:09Z [----] followers, [---] engagements
"$MCRB [--] Nov [----] We have engaged MTS Health Partners to facilitate the process Still nothing whats in going on we are in May Partnership Buyout 🤔 The latest rumors speak of an acquisition by Nestle. where there's smoke there's fire $NSRGY $JNJ $MRK $SGTX #biotech Seres Therapeutics Presents Data at the [----] Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics to Treat Inflammatory and Immune Diseases $MCRB https://t.co/1VfVETubGX Seres Therapeutics Presents Data at the [----] Digestive Disease Week Conference Highlighting the Potential for Live Biotherapeutics"
X Link 2025-05-05T18:10Z [----] followers, [---] engagements
"Good deal for FootLocker 👍🏼 $FL $DKS $DKS confirms $FL deal $24 cash or $DKS stock $DKS confirms $FL deal $24 cash or $DKS stock"
X Link 2025-05-15T10:05Z [----] followers, [---] engagements
"Normally news about FDA or partnership a due for next week Seres Therapeutics we touched the low Its time to run now In the same time Nestl to create industry-leading capabilities in bio tech $MCRB $NSRGY $LLY $JNJ $NVS https://www.nestle.com/media/pressreleases/allpressreleases/bio-tech-deep-tech-research-development $MCRB Earnings Call Highlights. They have had frequent recent contact with the FDA about phase [--] study design for SER-155 in patients undergoing allo-HSCT. They expect to submit a final design for approval to the FDA in about [--] weeks. They did not want to disclose many"
X Link 2025-05-15T14:18Z [----] followers, [---] engagements
"The human microbiome market is projected to expand at a CAGR of 20.42% growing from $941.215 million in [----] to $2.38 billion by [----]. $MCRB"
X Link 2025-06-23T16:06Z [----] followers, [---] engagements
"Soon a similar scenario with Seres therapeutics like Nektar therapeutics 🧪 $NKTR $MCRB #biotech The human microbiome market is projected to expand at a CAGR of 20.42% growing from $941.215 million in [----] to $2.38 billion by [----]. $MCRB The human microbiome market is projected to expand at a CAGR of 20.42% growing from $941.215 million in [----] to $2.38 billion by [----]. $MCRB"
X Link 2025-06-24T19:15Z [----] followers, [---] engagements
"@Investingcom Seres Therapeutics $MCRB"
X Link 2025-07-06T09:19Z [----] followers, [---] engagements
"Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB $MRK to acquire $VRNA for $107/ADS https://t.co/qtlcVzmXxz $MRK to acquire $VRNA for $107/ADS https://t.co/qtlcVzmXxz"
X Link 2025-07-09T10:41Z [----] followers, [---] engagements
"$MCRB Seres Therapeutics run a 100% in one month Thats smells good no $MRK $NVS $NSRGY $JNJ Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB"
X Link 2025-07-17T05:14Z [----] followers, [---] engagements
"Eric step down for one reason if now the future and know it will be not part of the planEngagements with several parties are underway regarding various deal structures including potential business development and partnership opportunities for Seres Therapeutics $MCRB $NSRGY Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB Merck acquire Verona for $107 Just to remember in May [----] Verona traded at $12 that represent a premium of 800% for one year Be patient 😉 $MRK $VRNA $MCRB"
X Link 2025-07-22T14:29Z [----] followers, [---] engagements
"@Biotech2k1 $MCRB 🚀"
X Link 2025-07-26T20:22Z [----] followers, [--] engagements
"Whats happen with the milestones payment of Nestl Last week communicate are very interesting - Engagements with several parties are underway regarding various deal structures including potential business development and partnership opportunities $MCRB Eric step down for one reason if now the future and know it will be not part of the planEngagements with several parties are underway regarding various deal structures including potential business development and partnership opportunities for Seres Therapeutics $MCRB $NSRGY Eric step down for one reason if now the future and know it will be not"
X Link 2025-07-29T14:59Z [----] followers, [---] engagements
"If you dont know Seres Therapeutics read this article whos explain the real gems 💎 After the announcement of the last week. Think that are on the final talks for something big Its your last chance to be part of the last train 🚂 $MCRB $NSRGY https://seekingalpha.com/article/4805623-serestherapeutics-speculative-gem-backed-by-ser155-fda-breakthrough https://seekingalpha.com/article/4805623-serestherapeutics-speculative-gem-backed-by-ser155-fda-breakthrough"
X Link 2025-07-31T07:13Z [----] followers, [---] engagements
"Maybe next Bo will be Okta $okta $comm Amphenol $APH is nearing a deal to buy CommScope Holdings $COMM broadband connectivity and cable unit The deal would be valued at roughly $10.5 billion including debt - WSJ Amphenol $APH is nearing a deal to buy CommScope Holdings $COMM broadband connectivity and cable unit The deal would be valued at roughly $10.5 billion including debt - WSJ"
X Link 2025-08-04T10:08Z [----] followers, [---] engagements
"Tomorrow its 6th August [----] and thats marks one year of the agreement of The deal with Nestle & Seres therapeutics published on the 6th August 2024Its time to close the chapter on the earning 🚀 $MCRB $NSRGY https://www.nestlehealthscience.com/newsroom/press-releases/nhs-agreement-vowst-global-rights https://www.nestlehealthscience.com/newsroom/press-releases/nhs-agreement-vowst-global-rights"
X Link 2025-08-05T15:57Z [----] followers, [---] engagements
"$ZVRA Zevra Therapeutics its a Bo candidate $BIIB $AMGN Sources familiar with the situation say the company has had multiple approaches around $20. They have recruited advisors to auction to the highest bidder from both US and Europe. @ZaksTradersCafe https://zakstraderscafe.com/zevra-therapeutics-nasdaqzvra-multiple-approaches/12387/ https://zakstraderscafe.com/zevra-therapeutics-nasdaqzvra-multiple-approaches/12387/"
X Link 2025-08-05T16:05Z [----] followers, [---] engagements
"@whichwaygo @ZaksTradersCafe 😂 Lets see what happen my friend give him a chance no"
X Link 2025-08-05T16:20Z [----] followers, [--] engagements
"Mmmm Seres Therapeutics whats is this options calls of October mean 15$ buyer for a value of 800K last week and yesterday buyer of 17.5$ for a value of 600K $MCRB $NSRGY $UNH #biotech #microbiome #optionsalerts Tomorrow its 6th August [----] and thats marks one year of the agreement of The deal with Nestle & Seres therapeutics published on the 6th August 2024Its time to close the chapter on the earning 🚀 https://t.co/cb17bnsh8B $MCRB $NSRGY Tomorrow its 6th August [----] and thats marks one year of the agreement of The deal with Nestle & Seres therapeutics published on the 6th August 2024Its"
X Link 2025-08-15T09:48Z [----] followers, [---] engagements
"Finally Seres Therapeutics received offers of Nestl for 41$ + 35$ CVR reported by Swiss media @InsideParade & @awp_de thats look not bad :) Probably the last time to buy more $MCRB $NSRGY #biotech $xbi $ibb Make your own DD and you understand Since [----] Nestl Health Science has invested big in Seres Therapeutics: [----] $66.5M + $30M 💵 [----] $175M + $125M 📈 [----] $175M + $18M 🔄 [----] $50M + $25M 💰 Total so far: $664.5M Potential: +$275M milestones #biotech #Nestle $NSRGY $MCRB https://t.co/nc7juq8TvB Make your own DD and you understand Since [----] Nestl Health Science has invested big in Seres"
X Link 2025-09-08T08:40Z [----] followers, [----] engagements
"Another one Tourmaline $TRML 48$ for Novartis $NVS good bye $RNA $XBI $IBB Novartis agrees to acquire Tourmaline Bio at an offer price of $48 per share in cash https://t.co/Q5EBFLMrRc Novartis agrees to acquire Tourmaline Bio at an offer price of $48 per share in cash https://t.co/Q5EBFLMrRc"
X Link 2025-09-09T05:42Z [----] followers, [----] engagements
"@monaco_biotech Have some problems with Seres Therapeutics $MCRB"
X Link 2025-09-13T00:46Z [----] followers, [---] engagements
"@monaco_biotech Seres therapeutics $MCRB"
X Link 2025-09-13T03:35Z [----] followers, [---] engagements
"the Sept [--] Nestl $41/share bid before settling lower. $NSRGY #biotech $xbi $ibb Outperformed the biotech sector dramatically. Trend phases: Light green zone = sustained uptrend Light gray zone = consolidation Salmon zone = September spike on Nestl news"
X Link 2025-09-13T04:18Z [----] followers, [---] engagements
"Its time to add more Zevra - $150M+in cash two FDA approved drugs including one for a rare disease $ZVRA #biotech $ZVRA Insider Purchase: Director at $ZVRA Buys [-----] Shares - Quiver Quantitative #stocks #news https://t.co/wyqOzEIxps $ZVRA Insider Purchase: Director at $ZVRA Buys [-----] Shares - Quiver Quantitative #stocks #news https://t.co/wyqOzEIxps"
X Link 2025-09-16T13:46Z [----] followers, [---] engagements
"Damn its Oracle year a deal per week🚨 $ORCL $ORCL ORACLE IN TALKS WITH META ON $20B AI CLOUD COMPUTING DEAL $ORCL ORACLE IN TALKS WITH META ON $20B AI CLOUD COMPUTING DEAL"
X Link 2025-09-19T20:08Z [----] followers, [--] engagements
"PFIZER $PFE WILL PAY METSERA $MTSR $47.50 IN CASH A SHARE AND A FURTHER $22.50 IF CERTAIN PERFORMANCE MILESTONES ARE MET What about $VKTX valued at 10bn 🤷🏻♂ #biotech $xbi $ibb Pfizer is closing in on a potential $7.3 billion takeover of obesity startup Metsera the Financial Times reported citing unidentified people familiar with the matter https://t.co/5fMo7L3DaX Pfizer is closing in on a potential $7.3 billion takeover of obesity startup Metsera the Financial Times reported citing unidentified people familiar with the matter https://t.co/5fMo7L3DaX"
X Link 2025-09-22T05:38Z [----] followers, [---] engagements
"Intel its still a buy Whats your target for the next month $INTC $ORCL $NVDA $AMD #tech #fintech #trump Intel stock is up 50% over the last month putting U.S. stake at $16 billion https://t.co/xjBcFBYHFT Intel stock is up 50% over the last month putting U.S. stake at $16 billion https://t.co/xjBcFBYHFT"
X Link 2025-10-02T17:46Z [----] followers, [---] engagements
"OpenAI non profit but a lot of partnerships 🤔 #openai #grook $NVDA $ORCL $GOOG $MSFT $CORE $AVGO $META $AMZN This is wild: A map of OpenAI's recent partnerships. Now one of the largest companies in the world worth over $500B still owned by a non-profit parent. What's next https://t.co/P8ZuwpDFOb This is wild: A map of OpenAI's recent partnerships. Now one of the largest companies in the world worth over $500B still owned by a non-profit parent. What's next https://t.co/P8ZuwpDFOb"
X Link 2025-10-08T15:30Z [----] followers, [---] engagements
"$SHOP next target $165 🤔 https://x.com/ophirgottlieb/status/997145481800073216 $SHOP Shopify Stock: Next Stop $165 @themotleyfool https://t.co/sK4DLWWUps - "Two analysts jack up their price targets on the e-commerce platform provider after a developer conference presentation" https://x.com/ophirgottlieb/status/997145481800073216 $SHOP Shopify Stock: Next Stop $165 @themotleyfool https://t.co/sK4DLWWUps - "Two analysts jack up their price targets on the e-commerce platform provider after a developer conference presentation""
X Link 2018-05-17T16:30Z [----] followers, [--] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing